UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March ~~September 30~~31, ~~2023~~ 2024

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File No.: 000-54624

~~bowmo~~Bowmo, ~~Inc~~inc. (Exact name of registrant as specified in its charter)

Wyoming		26-4144571
(State or other jurisdiction of incorporation)		(IRS Employer Identification No.)

99 Wall Street, Suite 891, New York City, New York 10005

(Address of principal executive offices)

(212) 398-0002

(Registrant’s telephone number, including area code)

Former name, former address and former fiscal year, if changed since last report

Indicate by check mark whether the registrant (1) has filed all reports to be filed by Section 13 and Section 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to files such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

☐	Large accelerated filer	☐	Accelerated filer
☒	Non-accelerated filer	☒	Smaller reporting company
		☐	Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12-b2 of the Exchange Act). Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common stock		BOMO		OTC Markets - Other

Indicate the number of shares outstanding of ~~each~~ each of the issuer’s classes of common stock, as of the latest practicable date. As of ~~November~~October 2111, ~~2023~~2024, there were 40136,~~763~~458,~~149~~010 shares of ~~Common~~common ~~Stock,~~stock ~~par value $0.00001 per shares~~ outstanding.

Table of Contents

PART I		1
Item 1.	Condensed Financial Statements	1
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	22
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	2625
Item 4.	Controls and Procedures	26
PART II		27
Item 1.	Legal Proceedings	2827
Item 1A.	Risk Factors	2827
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	2827
Item 3.	Defaults Upon Senior Securities	2827
Item 4.	Mining Safety Disclosures	2827
Item 5.	Other Information	2827
Item 6.	Exhibits	2827
	Signatures	2928

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements.

Condensed Consolidated Balance Sheets as September 30, 2023 (unaudited) and December 31, 2022	2
Consolidated Balance Sheets as March 31, 2024 (unaudited) and December 31, 2023	2
Condensed Consolidated Statements of Operations for the three months and nine months ended September 30, 2023 and 2022 (unaudited)	3
Consolidated Statements of Operations for the Three Months Ended March 31, 2024 and 2023 (unaudited)	3
Condensed Consolidated Statements of Stockholders’ Deficit for the three months and nine months ended September 30, 2023 and 2022 (unaudited)	4
Consolidated Statements of Stockholders’ Deficit for the Three Months Ended March 31, 2024 and 2023 (unaudited)	4
Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2023 and 2022 (unaudited)	5
Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2024 and 2023 (unaudited)	5
Notes to Condensed Consolidated Financial Statements (unaudited)	6

bowmo, Inc. and Subsidiaries ~~Condensed~~ Consolidated Balance Sheets

	September 30, 2023			December 31, 2022
	March 31, 2024			December 31, 2023 (audited)
				(as Restated)
ASSETS
Cash and cash equivalents	$	32,~~868~~009		$	~~167~~6,~~103~~308
Accounts receivable		-18,172			1518,~~542~~172
Prepaid expenses and other current assets		~~859~~45,388			~~858~~1,838
Total Current Assets		465,~~727~~569			~~183~~26,~~503~~318
Total Assets	$	465,~~727~~569		$	~~183~~26,~~503~~318
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities:
Accounts payable	$	~~952~~1,~~832~~189,952		$	~~813~~1,~~378~~144,755
Accrued expenses		~~200~~13,~~000~~500			~~200~~213,~~286~~696
Accrued interest		364,~~597~~598			~~366~~364,~~622~~598
Accrued officer compensation		1,~~398~~509,~~500~~499			1,~~074~~384,~~361~~499
Loans payable, current portion		~~192~~30,~~222~~000			~~113~~30,~~006~~000
Loans payable, related party		254,500			~~190~~254,500
Convertible notes, net of debt discount		896,425			669,581
Convertible Notes, net of debt discount		189,590			440,109
Put premium on stock settled debt		205,684			~~219~~205,~~687~~684
Derivative liability		2,389,588			2,172,250
Acquisition payable		200,000			-
Total Current Liabilities		6,854,348			5,819,671
Derivative liability		819,944			433,818
Loans payable, net of current portion		-			260,494
Total Current Liabilities		4,777,267			4,471,659
Total Liabilities		6,854,348			6,080,165
Loans payable, net of current portion		193,202			193,202
Total Liabilities		4,970,469			4,664,861
Commitments and Contingencies
STOCKHOLDERS’ DEFICIT:
Series A Preferred stock, 3,500,000 shares authorized, par value $0.01; 33,815 shares issued and outstanding as of September 30, 2023 and December 31, 2022		33,815			33,815
Series A Preferred stock, 3,500,000 shares authorized, par value $0.01; 3,381,520 and 0 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively		33,815			33,815
Series B Preferred stock, 10,000 shares authorized, par value $0.01; 50 shares issued and outstanding as of September 30, 2023 and December 31, 2022		50			50
Series B Preferred stock, 10,000 shares authorized, par value $0.01; 5,000 and 0 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively		50			50
Series C Preferred stock, 10,000,000 shares authorized, par value $0.01; 50,000 shares issued and outstanding as of September 30, 2023 and December 31, 2022		50,000			50,000
Series C Preferred stock, 10,000,000 shares authorized, par value $0.01; 5,000,000 and 0 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively		50,000			50,000
Series D Preferred stock, 125,000 shares authorized, par value $0.0001; 12 shares issued and outstanding as of September 30, 2023 and December 31, 2022		12			12
Series D Preferred stock, 125,000 shares authorized, par value $0.0001; 125,000 and 0 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively		12			12
Series E Preferred stock to be issued		166,331			166,331
Series G Preferred stock, 1,000,000 shares authorized, par value $0.0001; 10,000 shares issued and outstanding as of September 30, 2023 and December 31, 2022		1,000			1,000
Series F Preferred stock, 101 shares authorized, par value $0.0001; 101 and 0 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively		-			-
Series H Preferred stock, 1,000,000 shares authorized, par value $0.001; 100 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively.		10			10
Series G Preferred stock, 1,000,000 shares authorized, par value $0.0001; 1,000,000 and 0 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively		1,000			1,000
Common stock 40,000,000,000 shares authorized, $0.00001 par value; 333,609,842 and 270,497,364 shares issued and outstanding, respectively at September 30, 2023 and December 31, 2022, respectively		333,610			270,497
Series H Preferred stock, 10,000 shares authorized, par value $0.0001; 0 and 10 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively		-			10
Common stock to be issued, 25 shares as of September 30, 2023 and December 31, 2022		26			26
Series AA Preferred stock, 10,000,000 shares authorized, par value $0.0001; 0 and 652,259 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively		-			-
Treasury stock, at cost – 7,735 shares as of September 30, 2023 and December 31, 2022		(773,500	)		(773,500	)
Series Super Preferred stock, 10,000,000 shares authorized, par value $0.0001; 0 and 500 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively		-			-
Additional paid in capital		5,593,322			4,963,869
Common stock 40,000,000,000 shares authorized, $0.00001 par value; 109,541,546 and 53,520,830 shares issued and outstanding, respectively at March 31, 2024 and December 31, 2023*		1,096			535
Accumulated deficit		(12,254,297	)		(10,608,772	)
Common stock to be issued, 2,550,000 and 2,550,000 shares as of March 31, 2024 and December 31, 2023, respectively		26			26
Total Stockholders’ Deficit		(6,849,621	)		(5,896,662	)
Treasury stock, at cost 2,917 shares as of March 31, 2024 and December 31, 2023, respectively		(773,500	)		(773,500	)
Total Liabilities and Stockholders’ Deficit	$	4,727		$	183,503
Additional paid in capital *		9,161,022			8,876,064
Accumulated deficit		(13,544,752	)		(12,992,877	)
Total Stockholders’ Deficit		(4,904,900	)		(4,638,533	)
Total Liabilities and Stockholders’ Deficit	$	65,569		$	26,318

The accompanying notes are an integral part of these ~~unaudited condensed~~ consolidated financial statements.

Amounts have been adjusted by a 1000 to 1 reverse split during 2023.

bowmo, Inc. and Subsidiaries

~~Condensed~~ Consolidated ~~Statement~~Statements of Operations

(Unaudited)

	March 31, 2024			March 31, 2023
Revenue	$	-		$	4,476
Cost of revenue		-			-
Gross Profit		-			4,476

Operating Expenses
Compensation expense		125,000			121,314
Consulting fees		-			30,000
Professional fees		39,500			160,054
General and administrative		31,249			76,581
Total Operating Expenses		195,749			387,949

Loss from Operations		(195,749	)		(383,473	)

Other Income (Expenses)
Interest expense		-			(269,500	)
Gain on new methodology for accounting for debt conversion features		-
Initial recognition of derivative liability		-			(32,429	)
Change in fair value of derivative liability		(356,126	)		1,303,044
Total other income (expenses)		(356,126	)		1,001,115

Loss before income taxes		(551,875	)		617,642
Provision for income taxes		-			-

NET (Loss) Income	$	(551,875	)	$	617,642

Net loss per common share – basic and diluted	$	(0.01	)	$	0.00
Weighted average common shares – basic and diluted *		*109,541,546			28,158,862,202

	For the Nine Months Ended						For the Three Months Ended
	September 30			September 30			September 30			September 30
	2023			2022			2023			2022
				(as Restated)
REVENUES		66,476			149,848			62,000			-
Cost of Revenues		-			48,470			-			-
Gross Profit (Deficit)		66,476			101,378			62,000			-
Operating Expenses
Compensation expense		431,421			301,660			209,303			98,375
Consulting fees		90,000			1,486,514			30,000			75,000
Professional fees		166,884			247,837			3,415			117,119
General and administrative expenses		174,584			123,735			67,163			68,820
Total Operating Expenses		862,889			2,159,746			309,881			359,314
Loss from Operations		(796,413	)		(2,058,368	)		(247,881	)		(359,314	)
Other Income (Expense)
Interest expense		(666,774	)		(243,429	)		(169,369	)		(200,269	)
Gain on new methodology for accounting for debt conversion features		-			27,856			-			-
Initial recognition of derivative liability		(32,429	)		-			-			-
Change in fair value of derivative liability		149,909			(1,545	)		(580,189	)		-
Total Other Income		(849,112	)		(217,118	)		(749,558	)		(200,269	)
Net loss	$	(1,645,525	)	$	(2,275,486	)	$	(997,439	)	$	(559,583	)
Weighted average common shares outstanding:
Basic and Diluted		31,260,512			8,488,816			33,300,997			18,514,334
Earnings per common share:
Basic and Diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)

Amounts have been adjusted by a 1000 to 1 reverse split during 2023.

The accompanying notes are an integral part of these ~~unaudited condensed~~ consolidated financial statements.

bowmo, Inc. and Subsidiaries

Consolidated Statement of Changes in Stockholders’ Deficit For the Six Months Ended June 30, 2024 and 2023

For the Nine Months Ended September 30, 2023 and 2022

	Preferred Stock AA				Super Preferred Stock				Preferred Stock A				Preferred Stock B				Preferred Stock C				Preferred Stock D				Preferred Stock E				Preferred Stock G				Preferred Stock H					Common Stock				Common Stock to be issued												Total Equity
	Shares		Amount ($)		Shares		Amount ($)		Shares		Amount ($)		Shares		Amount ($)		Shares		Amount ($)		Shares		Amount ($)		Shares		Amount ($)		Shares		Amount ($)		Shares		Amount ($)			Shares		Amount ($)		Shares		Amount ($)		Additional Paid-in		Treasury Stock			Accumulated Deficit			Equity /(Deficit) $
Balance as of December 31, 2022		0	$	0		0	$	0		3,381,520	$	33,815		5,000	$	50		5,000,000	$	50,000		125,000	$	12		0	$	166,331		1,000,000	$	1,000		0	$	0			27,049,736,362	$	270,497		0	$	26	$	3,599,032	$	(773,500	)	$	(9,243,925	)	$	(5,896,662	)
Net Loss for 1st Quarter 2023																																																				617,642			617,642
Balance as of March 31, 2023		0	$	0		0	$	0		3,381,520	$	33,815		5,000	$	50		5,000,000	$	50,000		125,000	$	12		0	$	166,331		1,000,000	$	1,000		0	$	0			27,049,736,362	$	270,497		0	$	26	$	3,599,032	$	(773,500	)	$	(8,626,283	)	$	(5,279,020	)

Balance as of December 31, 2023		0		0		0		0		3,381,520		33,815		5,000		50		5,000,000		50,000		125,000		12		0	$	166,331		1,000,000	$	1,000		10,000	$	10			53,520,830	$	535		0	$	26	$	8,876,064	$	(773,500	)	$	(12,992,877	)	$	(4,638,533	)
Equity Issuance Q1 2024																																			$	(10	)		56,020,726	$	560					$	284,958							$	285,508
Net Loss for 1st Quarter 2024																																																				(551,875	)		(551,875	)
Balance as of March 31, 2024		0	$	0		0	$	0		3,381,520	$	33,815		5,000	$	50		5,000,000	$	50,000		125,000	$	12		0	$	166,331		1,000,000	$	1,000		10,000	$	0			109,541,556	$	1,096		0	$	26	$	9,161,022	$	(773,500	)	$	(13,544,752	)	$	(4,904,900	)

~~(Unaudited)~~The accompanying notes are an integral part of these consolidated financial statements.

~~(as~~Kindly ~~Restated)~~present the Statement of Changes in Stockholders’ Deficit for the period under review, March 31, 2024

	Series A				Series B				Series C				Series D				Series F				Series G				Series E Preferred				Series H								Common		Additional
	Preferred Stock				Preferred Stock				Preferred Stock				Preferred Stock				Preferred Stock				Preferred Stock				Stock to be issued				Preferred Stock				Common Stock				Stock to		Paid-In			Treasury			Accumulated
	Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount		be Issued		Capital			Stock			Deficit			Total
Balance December 31, 2021		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		181,500		18,150		-		3,802,391			-			(4,663,488	)		(842,294	)
Net loss		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-			-			(64,062	)		(64,062	)
Balance, March 31, 2022		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		181,500		18,150		-		3,802,391			-			(4,727,550	)		(906,356	)
Recapitalization at reverse merger - May 4, 2022		33,815		33,815		50		50		50,000		50,000		1,250		12		1		-		10,000		1,000		-		166,331		-		-		89,368,645		71,400		26		(2,630,899	)		(773,500	)		-			(3,082,418	)
Warrants issued		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		306,220			-			-			306,220
Shares issued for extinguishment of convertible debt		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		66,739,603		66,740		-		532,379			-			-			599,119
Shares issued in exchange for services		-		-		-		-		-		-		-		-		-		-		-		-		-		-		100		10		-		-		-		1,364,837			-			-			1,364,847
Net loss		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-			-			(1,651,841	)		(1,651,841	)
Balance, June 30, 2022		33,815		33,815		50		50		50,000		50,000		1,250		12		1		-		10,000		1,000		-		166,331		100		10		156,289,748		156,290		26		3,374,928			(773,500	)		(6,379,391	)		(3,370,429	)
Shares issued for extinguishment of convertible debt		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		62,068,418		62,068		-		676,812			-			-			738,880
Warrants issued with convertible debt																																								24,963			-			-			24,963
Net loss		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-			-			(559,583	)		(559,583	)
Balance, September 30, 2022		33,815		33,815		50		50		50,000		50,000		1,250		12		1		-		10,000		1,000		-		166,331				10		218,358,166		218,358		26		4,076,703			(773,500	)		(6,938,974	)		(3,166,169	)

	Series A				Series B				Series C				Series D				Series F				Series G				Series E Preferred				Series H								Common		Additional
	Preferred Stock				Preferred Stock				Preferred Stock				Preferred Stock				Preferred Stock				Preferred Stock				Stock to be issued				Preferred Stock				Common Stock				Stock to		Paid-In		Treasury			Accumulated
	Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount		be Issued		Capital		Stock			Deficit			Total
Balance December 31, 2022		33,815		33,815		50		50		50,000-		50,000		1,250		12		1		-		10,000		1,000		-		166,331		100		10		270,497,364		270,497		26		4,963,869		(773,500	)		(10,608,772	)		(5,896,662	)
Stock-based compensation		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		28,314		-			-			28,314
Relative fair value of warrants issued with convertible debt		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		14,995		-			-			14,995
Shares issued for extinguishment of convertible debt		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		42,473,831		42,474		-		376,113		-			-			418,587
Net income		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-			617,642			617,642
Balance, March 31, 2023		33,815		33,815		50		50		50,000		50,000		1,250		12		1		-		10,000		1,000		-		166,331		100		10		312,971,195		312,971		26		5,383,291		(773,500	)		(9,991,130	)		(4,817,124	)
Stock-based compensation		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		28,314		-			-			28,314
Relative fair value of warrants issued with convertible debt		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		9,994		-			-			9,994
Shares issued for extinguishment of convertible debt		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		11,440,580		11,441		-		94,618		-			-			106,059
Net loss		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-			(1,265,728	)		(1,265,728	)
Balance, June 30, 2023		33,815		33,815		50		50		50,000		50,000		1,250		12		1		-		10,000		1,000		-		166,331		100		10		324,411,774		324,412		26		5,516,217		(773,500	)		(11,256,858	)		(5,938,485	)
Stock-based compensation		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		29,257		-			-			29,257
Shares issued for extinguishment of convertible debt		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		9,198,068		9,198		-		47,848		-			-			57,046
Net loss		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-		-			(997,439	)		(997,439	)
Balance, September 30, 2023		33,815		33,815		50		50		50,000		50,000		1,250		12		1		-		10,000		1,000		-		166,331		100		10		333,609,842		333,610		26		5,593,322		(773,500	)		(12,254,297	)		(6,849,621	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

bowmo, Inc. and Subsidiaries ~~Condensed Consolidated Statements of Cash Flows (Unaudited)~~

	September 30,			September 30,
	2023			2022
				(as Restated)
Cash Flows from Operating Activities
Net income (loss)	$	(1,645,525	)	$	(2,275,486	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Convertible debt issued for services		-
Interest expense incurred on put premium on stock settled debt		111,000			60,717
Change in fair value of derivative liability		149,910			1,545
Amortization of debt discount		418,163			109,236
Stock-based compensation and shares issued for services		265,802			1,488,604
Gain on new methodology for accounting for debt conversion features		-			(27,856	)
Expenses incurred on extinguishment of convertible debt and accrued interest		23,905			90,246
Initial derivative expense		32,429			-
Changes in operating assets and liabilities (net of amounts acquired):
Accounts receivable		15,543			37,638
Accounts payable		139,454			-
Accrued expenses		(286	)		-
Accrued interest		30,511			73,485
Accrued compensation		324,139			22,565
Deferred revenue		-			(3,108	)
Net Cash (Used In) Operating Activities		(134,957	)		(422,414	)
Cash Flows from Investing Activities
Cash acquired in Reverse Merger		-			517
Net Cash Provided by Investing Activities		-			517
Cash Flows from Financing Activities
Payments of loans payable		-			-
Proceeds from loans payable		(117,278	)		269,100
Proceeds from convertible notes payable		89,000			247,500
Net Cash Provided by Financing Activities		(28,278	)		516,600
Net Change in Cash and Cash Equivalents		(163,235	)		94,703
Cash And Cash Equivalents - Beginning of Period		167,103			382
Cash And Cash Equivalents - End of Period	$	3,868		$	95,085

Consolidated Statements of Cash Flows

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

	March 31,			March 31,
	2024			2023
Cash Flows from Operating Activities
Net loss	$	(551,875	)	$	617,642
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Interest expense incurred on put premium on stock settled debt		(30,000	)		30,000
Amortization of debt discount		-			245,146
Stock-based compensation and shares issued for services		-			96,314
Expenses incurred on extinguishment of convertible debt and accrued interest		-			17.075
Initial derivative expense		-			32.429
Change in fair value of derivative liability		356,126			(1,303,044	)
Changes in operating assets and liabilities (net of amounts acquired):
Accounts receivable		-			15,542
Prepaid expenses and other current assets		(43,550	)		-
Accounts payable		60,197			138,972
Accrued expenses		(200,197	)		(286	)
Accrued Interest		-			(8,127	)
Accrued compensation		125,000			38,850
Acquisition payable		200,000			-
Net Cash (Used In) Provided By Operating Activities		(84,299	)		(79,487	)

Cash Flows from Investing Activities
Cash acquired in reverse merger		-			-
Cash acquired in acquisition		-			-
Net Cash Provided by Investing Activities		-			-

Cash Flows from Financing Activities
Proceeds from loans payable		15,000			-
Proceeds from equity issuances		285,518			-
Repayment of loans		(220,518	)		-
Net Cash Provided by Financing Activities		80,000			-

Net Change in Cash and Cash Equivalents		(4,299	)		(79,487	)

Cash And Cash Equivalents - Beginning of Year		6,308			167,103

Cash And Cash Equivalents - End of Year		2,009		$	87,616

Supplemental Disclosure of Cash and Non-cash Transactions:
Cash paid for interest	$			$
Cash paid for interest	$			$
Non-Cash Transaction Conversion of convertible debt to Common Stock	$	285,518		$

The accompanying notes are an integral part of these consolidated financial statements

bowmo, Inc. and Subsidiaries

Notes to ~~Unaudited~~the ~~Condensed~~Audited Consolidated Financial Statements

~~September~~For 30the Three Months Ended March 31, 2024 and 2023

NOTE 1 – ~~RESTATEMENT~~ BACKGROUND

The Company filed the Original Form 10-Q on November 18, 2022. After the filing of the Original Form 10-Q, the Company determined that had not recognized the issuance of 10 Shares of its Series H preferred stock and the related consulting expense. The accompanying condensed consolidated financial statements have been restated to reflect the issuance of the Series H preferred stock.

We have restated certain amounts as previously disclosed within the September 30, 2022, Original Form 10-Q condensed consolidated balance sheets to conform to our presentation in this Amendment.

The table below presents the impact of the Restatement within certain equity accounts as of September 30, 2023, and December 31, 2022. The values as previously reported were derived from the Original Form 10-Q.

	As of September 30, 2023
	As Previously Reported			Adjustments			As Restated
STOCKHOLDERS’ DEFICIT:
Series H Preferred stock, 10,000 shares authorized, par value $0.001; 100 and 100 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively.		-			10			10
Additional paid in capital		4,228,485			1,364,837			5,593,322
Accumulated deficit		(10,889,450	)		(1,364,847	)		(12,254,297	)
Total Stockholders’ Deficit		(6,849,621	)		-			(6,849,621	)
Total Liabilities and Stockholders’ Deficit	$	4,727		$	-		$	4,727

	As of December 31, 2022
	As Previously Reported			Adjustments			As Restated
STOCKHOLDERS’ DEFICIT:
Series H Preferred stock, 10,000 shares authorized, par value $0.001; 100 and 0 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively.		-			10			10
Additional paid in capital		3,599,032			1,364,837			4,963,869
Accumulated deficit		(9,243,925	)		(1,364,847	)		(10,608,772	)
Total Stockholders’ Deficit		(5,896,662	)		-			(5,896,662	)
Total Liabilities and Stockholders’ Deficit	$	183,503		$	-		$	183,503

The following table presents the impact of the Restatement on certain accounts of the Company’s previously reported Condensed Consolidated Statements of Operations as applicable for the nine months ended September 30, 2022.

	Nine Months Ended September 30, 2022
	As Previously Reported			Adjustments			As Restated
Operating Expenses
Consulting Fees		121,667			1,364,847			1,486,514
Total Operating Expenses		794,899			1,364,847			2,159,746
Loss from Operations		(693,521	)		(1,364,847	)		(2,058,368	)
Net loss	$	(910,639	)	$	(1,364,847	)	$	(2,275,486	)

The following table presents the impact of the Restatement on the Company’s previously reported Condensed Consolidated Cash Flows (Used in) Operations as applicable for the nine months ended September 30, 2022:

	Nine Months Ended September 30, 2022
	As Previously Reported			Adjustments			As Restated
Net loss	$	(910,639	)	$	(1,364,847	)	$	(2,275,486	)
Stock-based compensation		123,757			1,364,847			1,488,604
Net cash (used in) operating activities	$	(422,414	)		-		$	(422,414	)

NOTE 2 – SUMMARY OF BUSINESS AND BASIS OF PRESENTATION

Reverse Merger and Corporate Restructure

On May 4, 2022, Cruzani, Inc. (“Cruzani” or the “Predecessor”) entered into a merger agreement (the “Merger Agreement”) with Bowmo, Inc. (“Bowmo” ~~or the “Company”~~) and Bowmo Merger Sub, Inc. to acquire Bowmo. (the “Acquisition”). The transactions contemplated by the Merger Agreement were consummated on May 4, 2022, and, pursuant to the terms of the Merger Agreement, all outstanding shares of Bowmo were exchanged for shares of Cruzani’s common stock and Bowmo became Cruzani’s wholly owned subsidiary.

The ~~Merger~~merger was effected pursuant to the Merger Agreement. The ~~Merger~~merger is being accounted for as a reverse merger whereby: Bowmo is ~~considered~~the acquirer for accounting purposes. Bowmo is considered the acquiring company for accounting purposes as upon completion of the Merger, Bowmo’s former stockholders held a majority of the voting interest of the combined company.

Pursuant to the ~~Merger~~merger, the Company issued Series G Preferred Stock holding the voting rights to 78% of the total voting equity securities to Bowmo’s stockholders. Upon completion of the acquisition, Bowmo is treated as the surviving entity and accounting acquirer although Cruzani was the legal acquirer. Accordingly, the historical financial statements are those of Bowmo.

~~Upon~~Accounting ~~completion~~for ofReverse ~~the acquisition, bowmo is treated as the surviving entity and accounting acquirer although Cruzani was the legal acquirer. Accordingly, the historical financial statements are those of Bowmo.~~Merger

The fair value of Cruzani assets acquired and liabilities assumed was based upon management’s estimates.

The following table summarizes the allocation of purchase price of the acquisition: 

Tangible Assets Acquired:	Allocation
Cash and cash equivalents		517
Accounts payable		(326,400	)
Accrued interest		(1,197,027	)
Accrued officer compensation		(453,333	)
Convertible Notes		(620,933	)
Put premium on stock settled debt		(230,743	)
Loans payable		(254,500	)
Net Tangible Assets Acquired	$	(3,082,419	)

Equity Acquired:
Series A Preferred stock, 3,500,000 shares authorized, par value $0.01; 3,381,520 shares issued and outstanding		(33,815	)
Series B Preferred stock, 10,000 shares authorized, par value $0.01; 5,000 shares issued and outstanding		(50	)
Series C Preferred stock, 10,000,000 shares authorized, par value $0.01; 5,000,000 shares issued and outstanding		(50,000	)
Series D Preferred stock, 125,000 shares authorized, par value $0.0001; 125,000 shares issued and outstanding		(12	)
Series E Preferred stock to be issued		(166,331	)
Series F Preferred stock, 101 shares authorized, par value $0.0001; 101 shares issued and outstanding		-
Common stock 20,000,000,000 shares authorized, $0.00001 par value; 8,955,014,498 shares issued and outstanding		(89,550	)
Treasury stock, at cost – 2,917 shares		773,500
Additional paid in capital		(2,648,676	)

Consideration:
Series G Preferred Stock holding the voting rights to 78% of the total voting equity securities to Bowmo’s stockholders		1,000

Organization and Business

Bowmo, Inc. (FKA Cruzani, Inc.) (the “Company”) is an AI-powered recruiting platform. The Company’s principal lines of business are direct placement of candidates with employers and Recruiting as a Service which allows the Company’s customers to outsource the management of their recruiting process to the Company. The Company offers recruiting software and services through an online AI-driven platform to connect potential candidates to employers for all businesses looking to address hiring needs. The Company was incorporated as a Delaware corporation in 2016.

~~The Company offers recruiting software and services through an online AI-driven platform to connect potential candidates to employers for all businesses looking to address hiring needs.~~6

~~The Company~~NOTE ~~was~~2 ~~incorporated~~– asGOING ~~a Delaware corporation in 2016.~~ CONCERN

The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles which contemplate continuation of the Company as a going-concern basis. The going concern basis assumes that assets are realized, and liabilities are extinguished in the ordinary course of business at amounts disclosed in the consolidated financial statements. The Company has incurred recurring losses from operations.

The Company incurred a net loss for the three months ended March 31, 2024, of $551,875, of which approximately $195,749 was due to operations and the remainder was due primarily to interest expense and derivative liabilities. At March 31, 2024, the Company has a working capital deficit of $4,711,698 and an accumulated deficit of $13,544,752

The Company’s ability to continue as a going concern depends upon its ability to obtain adequate funding to support its operations through continuing investments of debt and/or equity by qualified investors/creditors, internally generated working capital and monetization of intellectual property assets. These factors raise substantial doubt about the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Management is currently pursuing a business strategy which includes raising the necessary funds to finance the Company’s development and marketing efforts.

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The ~~accompanying~~Company’s ~~unaudited interim consolidated condensed~~ financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“~~U.S.~~ GAAP”).The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the ~~Securities~~reported amounts of assets and ~~Exchange~~liabilities ~~Commission~~and ~~for~~disclosure ~~interim~~of contingent assets and liabilities at the date of the financial statements ~~which~~and ~~omit~~the ~~certain~~reported ~~disclosures~~amounts of revenues and expenses during the reporting period. Actual results ~~These~~could ~~unaudited~~differ ~~consolidated~~from ~~condensed~~those ~~financial~~estimates. ~~statements~~Management ~~should~~further beacknowledges ~~read~~that init ~~conjunction~~is ~~with~~solely ~~the~~responsible ~~audited~~for ~~financial~~adopting ~~statements~~sound ~~and~~accounting ~~footnotes~~practices, ~~for~~establishing ~~the~~and ~~year~~maintaining ~~ended~~a ~~December~~system ~~31,~~of ~~2022~~internal ~~included~~accounting oncontrol ~~the~~and ~~Company’s~~preventing ~~Form~~and ~~10-K~~detecting fraud. The ~~results~~Company’s system of ~~the~~internal accounting ~~three~~control ~~months~~is ~~and~~designed ~~nine~~to ~~months~~assure, ~~ended September~~among 30other items, ~~2023~~that (1) recorded transactions are ~~not~~valid; ~~necessarily~~(2) ~~indicative~~valid oftransactions are recorded; and (3) transactions are recorded in the ~~results~~proper period in a timely manner to beproduce ~~expected~~financial ~~for~~statements which present fairly the ~~full~~financial condition, ~~year~~results ~~ending~~of ~~December~~operations ~~31,~~and ~~2023~~cash flows of the Company for the respective periods being presented.

On October 10, 2023, the Company effected a reverse split of its authorized and issued and outstanding common stock, par value $0.00001 at a ratio of 1:100. All information included in these consolidated financial statements has been adjusted, on a retrospective basis, to reflect the Reverse Share Split, unless otherwise stated.

In the opinion of management, all adjustments necessary to present fairly the financial position as of September 30, 2023 and the results of operations and cash flows presented herein have been included in the financial statements. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results of operations for the full year.

Principles of Consolidation

The accompanying unaudited interim consolidated condensed financial statements include the accounts of the Company and its subsidiaries. Intercompany transactions and balances have been eliminated. All financial information has been prepared in conformity with accounting principles generally accepted in the United States of America. All significant intercompany transactions and balances have been eliminated.

Use of Estimates

The preparation of financial statements in conformity with ~~generally~~GAAP ~~accepted accounting principles~~ requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, ~~and~~ disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company’s stock, stock-based compensation, fair values relating to derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results ~~could~~may differ from ~~those~~these estimates.

COVID-19 Impacts on Accounting Policies and Estimates

COVID-19 Impacts on Accounting Policies and Estimates In light of the currently unknown ultimate duration and severity of COVID-19, we face a greater degree of uncertainty than normal in making the judgments and estimates needed to apply our significant accounting policies. As COVID-19 continues to develop, we may make changes to these estimates and judgments over time, which could result in meaningful impacts to our financial statements in future periods.

Principals of Consolidation

The consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP). The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated.

Cash and Cash Equivalents

The Company accounts for cash and cash equivalents under FASB ASC 305, Cash and Cash Equivalents, and considers all highly liquid investments with an original maturity of three months or less ~~when purchased~~ to be cash equivalents. At March 31, 2024 and 2023, the Company had cash and cash equivalents of $2,009 and $87,616, respectively. There are no amounts that are uninsured by the FDIC (Federal Deposit Insurance Corporation).

~~Concentrations of Credit Risk~~7

WeDeferred ~~maintain~~Income ~~our~~Taxes ~~cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships~~ and ~~consequently have~~Valuation ~~not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.~~Allowance

~~Fair~~We ~~value~~recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial ~~instruments~~statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the years ended December 31, 2023 and 2022, respectively, due to cumulative losses, we recorded a valuation allowance against our deferred tax asset that reduced our income tax benefit for the period to zero. As of December 31, 2023 and 2022, we had no liabilities related to federal or state income taxes and the carrying value of our deferred tax asset was zero.

The Company ~~follows~~accounts ~~paragraph~~for ~~825-10-50-10~~income ~~of the~~taxes applying FASB ~~Accounting~~ASC ~~Standards~~740, ~~Codification~~which ~~for~~requires ~~disclosures~~the ~~about~~recognition ~~fair value~~ of ~~its~~deferred ~~financial~~tax ~~instruments~~liabilities and ~~paragraph~~assets ~~820-10-35-37~~for ~~of the~~expected ~~FASB~~future ~~Accounting~~tax ~~Standards~~consequences ~~Codification (“Paragraph 820-10-35-37”) to measure the fair value~~ of ~~its~~events ~~financial instruments.~~that ~~Paragraph~~have ~~820-10-35-37~~been ~~establishes~~included ~~a framework for measuring fair value~~ in ~~accounting~~the ~~principles~~financial ~~generally~~statements ~~accepted~~or intax ~~the~~returns. ~~United~~Under ~~States of~~this ~~America (U.S. GAAP)~~method, ~~and~~deferred ~~expands~~tax ~~disclosures~~liabilities ~~about fair value measurements. To increase consistency~~ and ~~comparability~~assets inare ~~fair~~determined ~~value~~based ~~measurements~~on ~~and~~the ~~related~~difference ~~disclosures,~~between ~~Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes~~ the ~~inputs~~financial tostatement ~~valuation techniques~~and ~~used~~tax tobases ~~measure~~of ~~fair~~assets ~~value~~and ~~into~~liabilities ~~three~~using ~~(3)~~enacted ~~broad~~tax ~~levels.~~rates ~~The~~in ~~fair~~effect ~~value~~for ~~hierarchy gives~~ the ~~highest priority to quoted prices~~year ~~(unadjusted)~~ in ~~active~~which ~~markets for identical assets or liabilities and~~ the ~~lowest~~differences ~~priority~~are expected to ~~unobservable inputs~~reverse. ~~The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:~~

~~Level~~Financial ~~1: Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.~~Instruments

~~Level~~The 2:Company ~~Pricing~~adopted ~~inputs~~the ~~other~~provisions ~~than~~of ~~quoted~~Accounting Standards ~~prices~~Codification insubtopic ~~active~~825-10, ~~markets~~Financial ~~included~~Instruments in(“ASC ~~Level~~825-10”) on January 1, 2008. ASC 825-10 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which ~~are~~it ~~either~~would ~~directly~~transact and considers assumptions that market participants would use when pricing the asset or ~~indirectly~~liability, ~~observable~~such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the ~~reporting~~use ~~date~~of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that may be used to measure fair value:

Level 3:1 ~~Pricing~~– ~~inputs~~Quoted ~~that~~prices ~~are~~in ~~generally~~active ~~unobservable~~markets ~~inputs~~for ~~and~~identical ~~not~~assets ~~corroborated~~or ~~by market data~~liabilities.

~~The~~Level ~~carrying~~2 ~~amount~~– ofObservable ~~the~~inputs ~~Company’s~~other ~~financial assets~~than ~~and~~Level ~~liabilities,~~1 prices such as ~~cash,~~quoted ~~prepaid~~prices ~~expenses~~for ~~and~~similar ~~accrued~~assets ~~expenses~~or ~~approximate~~liabilities; ~~their~~quoted ~~fair~~prices ~~value~~in ~~because~~markets ofwith ~~the~~insufficient ~~short~~volume ~~maturity of~~or ~~those~~infrequent ~~instruments.~~transactions ~~The~~(less ~~Company’s~~active ~~notes~~markets); ~~payable~~or ~~approximates~~model-derived ~~the~~valuations ~~fair~~in ~~value~~which ofall ~~such~~significant ~~instruments~~inputs ~~based~~are ~~upon~~observable ~~management’s best~~or ~~estimate~~can ofbe ~~interest~~derived ~~rates~~principally ~~that~~from ~~would~~or becorroborated ~~available~~by toobservable ~~the~~market ~~Company~~data for ~~similar~~substantially ~~financial~~the ~~arrangements~~full atterm ~~September~~of ~~30,~~the ~~2023~~assets ~~and~~or ~~December 31, 2022~~liabilities.

Level 3 –

Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.

All items required to be recorded or measured on a recurring basis are based upon level 3 inputs. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.

Upon adoption of ASC 825-10, there was no cumulative effect adjustment to beginning retained earnings and no impact on the financial statements.

The carrying value of the Company’s cash and cash equivalents, accounts receivable, accounts payable, short-term borrowings (including convertible notes payable), and other current assets and liabilities approximate fair value because of their short-term maturity.

Convertible Instruments

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with various accounting standards.

ASC 480 “Distinguishing Liabilities From Equity” provides that instruments convertible predominantly at a fixed rate resulting in a fixed monetary amount due upon conversion with a variable quantity of shares (“stock settled debt”) be recorded as a liability at the fixed monetary amount.

ASC 815 “Derivatives and Hedging” generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. Professional standards also provide an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of Conventional Convertible Debt Instrument.”

The Company accounts for convertible instruments (when it has determined that the instrument is not a stock settled debt and the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the share transaction and the effective conversion price embedded in the preferred shares.

ASC 815-40 provides that generally if an event is not within the entity’s control and could require net cash settlement, then the contract shall be classified as an asset or a liability.

Convertible Notes with Fixed Rate Conversion Options

The Company may enter into convertible notes, some of which contain, predominantly, fixed rate conversion features, whereby the outstanding principal and accrued interest may be converted by the holder, into common shares at a fixed discount to the market price of the common stock at the time of conversion. This results in a fair value of the convertible note being equal to a fixed monetary amount. The Company records the convertible note liability as stock settled debt in accordance with ASC 480 - “Distinguishing Liabilities from Equity” and measures the convertible note at its fixed monetary amount, which is the result of the share price discount at the time of conversion, and records the put premium, as applicable, on the note date with a charge to interest expense.

Derivative Instruments

The Company’s derivative financial instruments consist of derivatives with the sale of a convertible notes in ~~2022~~2023. The accounting treatment of derivative financial instruments requires that the Company records the derivatives at their fair values as of the inception date of the debt agreements and at fair value as of each subsequent balance sheet date. The carrying value assigned to the host instrument will be the difference between the previous carrying value of the host instrument and the fair value of the derivatives. There is an offsetting debt discount or premium as a result of the fair value assigned to the derivatives, as well as any debt issuance costs, which are amortized under the straight-line method over the term of the loan. Any change in fair value is recorded as non-operating, non-cash income or expense at each balance sheet date. If the fair value of the derivatives was higher at the subsequent balance sheet date, the Company recorded a non-operating, non-cash charge. If the fair value of the derivatives was lower at the subsequent balance sheet date, the Company recorded non-operating, non-cash income.

Business Combinations

The Company accounts for its business combinations using the acquisition method of accounting. Under the acquisition method, assets acquired, liabilities assumed, and consideration transferred are recorded at the date of acquisition at their respective fair values. Definite-lived intangible assets are amortized over the expected life of the asset. Any excess of the purchase price over the estimated fair values of the net assets acquired is recorded as goodwill.

Goodwill represents the excess purchase price over the fair value of the tangible net assets and intangible assets acquired in a business combination. Acquisition-related expenses are recognized separately from business combinations and are expensed as incurred. The Company remeasures fair value as of each reporting date and changes resulting from events after the acquisition date, are recognized as follows: 1) if the contingent consideration is classified as equity, the contingent consideration is not re-measured and its subsequent settlement is accounted for within equity, or 2) if the contingent consideration is classified as a liability, the changes in fair value and accretion costs are recognized in earnings.

Revenue Recognition

~~The~~For ~~Company~~annual ~~recognizes~~reporting ~~revenue~~periods inafter ~~accordance~~December ~~with~~15, 2017, the Financial Accounting Standards Board (“FASB”) ~~Accounting~~made ~~Standards~~effective ~~Codification~~ASU ~~(“ASC”)~~2014-09 ~~Topic 606, “~~Revenue from Contracts with Customers”, to ~~(“ASC~~supersede ~~606”).~~previous ~~Revenues~~revenue ~~are~~recognition ~~recognized~~guidance ~~when~~under ~~control~~current isU.S. ~~transferred~~GAAP. toRevenue ~~customers~~is now recognized in ~~amounts~~accordance with FASB ASC Topic ~~that~~606, ~~reflect~~Revenue ~~the~~Recognition. ~~consideration~~The objective of the ~~Company~~guidance ~~expects~~is to beestablish ~~entitled~~the toprinciples ~~receive~~that inan ~~exchange~~entity ~~for~~shall ~~those~~apply ~~goods.~~to ~~Revenue~~report ~~recognition~~useful information isto ~~evaluated through~~users of financial statements about the ~~following~~nature, ~~five~~amount, ~~steps:~~timing, ~~(1)~~and ~~identification~~uncertainty of ~~the~~revenue ~~contract,~~and orcash ~~contracts,~~flows arising from a contract with a customer;. ~~(2)~~The ~~identification~~principle ofis ~~the~~to ~~performance obligations~~recognize inrevenue ~~the~~to ~~contract;~~depict ~~(3)~~the ~~determination~~transfer of ~~the~~promised ~~transaction~~services ~~price;~~to ~~(4)~~customers ~~allocation~~in ofan ~~the~~amount that ~~transaction~~reflects ~~price~~the consideration to which the ~~performance~~Company ~~obligations~~ expects to be entitled in ~~the~~exchange ~~contract;~~for ~~and~~those ~~(5)~~services. ~~recognition~~Two options were made available for implementation of ~~revenue~~the ~~when~~standard: the full retrospective approach or asmodified aretrospective ~~performance~~approach. ~~obligation~~The isguidance ~~satisfied~~became effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period, with early adoption permitted.

The Company generates revenue from ~~the~~(1) ~~following~~Recruiting ~~activities:~~as a Service (“Raas”), and (2) Direct Placement.

Recruiting as a Service ~~(“RaaS”)~~:

RaaS allows the Company’s customers to outsource the management of their recruiting process allowing the Company to use the Application to assist its customers hiring needs by strategically gearing the service to reach the customer’s objectives. Revenue from RaaS consists of monthly billing to the customer for services provided.

RaaS service contracts with customers are month-to-month for a fixed price. Revenues are recognized on a gross basis when each monthly subscription service is completed.

Direct Placement:

The Company generates direct placement revenue by earning one-time fees for each time an employer hires one of the candidates that the Company refers. The Company sources qualified candidate referrals for the employers’ available jobs through the use of the Company’s Application. Upon the employer hiring one or more of the Company’s candidate referrals, the Company earns the direct placement fee, which consists of an amount agreed upon between the Company and its customers. The fee is a percentage of the referred candidates’ first year’s base salary.

Direct placement revenues are recognized on a gross basis on the date of hire of the candidate placed with an employer, as it is more than probable that a significant revenue reversal will not occur. This fee is only charged to the employer. Any payments received prior to the hire date are recorded as deferred revenue on the consolidated balance sheets. Payments for recruitment services are typically due within 30 days of completion of services.

Direct placement revenue is subject to a 90-180 ~~day~~ day guarantee that the candidate will not resign or be terminated in that time period. The Company uses historical evidence as well as ~~additional~~ additional factors to determine and estimate the amount of consideration received that the Company does not expect to be entitled to. For any amounts received for which the Company does not expect to be entitled, it would not recognize revenue when the candidate is hired but would recognize those amounts received as a refund liability. The Company included in the transaction price the estimated amount of variable consideration per the expected value method. A refund liability would be credited for the difference between cash consideration received and variable consideration recognized. The refund liability would be updated at the end of each reporting period for any changes in circumstances. As of ~~September~~December 3031, 2023 and ~~December 31,~~ 2022 ~~there was no refund liability on the unaudited condensed consolidated balance sheets as historically no direct placement revenue has been refunded to the Company.~~

~~Revenue~~ there ~~Disaggregation~~was no refund liability on the consolidated balance sheets as historically no direct placement revenue has been refunded to the Company.

~~For~~Revenue ~~the three months and nine months ended September 30, 2023 and 2022, revenues can be categorized into the following:~~Segementation

	For the three months ended				For the nine months ended
	September 30, 2023		September 30, 2022		September 30, 2023		September 30, 2022
Direct placement	$	62,000	$	-	$	62,000	$	100,750
Recruiting as a Service		-		-		4,476		49,098
Total revenues	$	62,000	$	-	$	686,476	$	149,848

For three months ended March 31, 2024, and the year ended December 31, 2023, revenues can be categorized into the following:

	March 31, 2024		December 31, 2023

Direct placement	$	-	$	78,458
Recruiting as a Service		-		169,976	*
Total revenues	$	-	$	243,434

(the $169,976 was a result the difference between $78,458 and the other unidentified revenue accounts)

Cost of revenues

Cost of revenue ~~consists~~consist of employee costs, third party staffing costs, hosting service fees, and other fees, outsourced recruiter fees and commissions.

Concentrations of credit risk

Financial instruments which potentially subject the Company to credit risks consist primarily of cash and cash equivalents and accounts receivable. Cash and cash equivalents are held in United States financial institutions. At times, such amounts may exceed federally insured limits.

AsConcentrations of ~~September~~credit ~~30, 2023, the Company had a zero balance in accounts receivable. As of December 31, 2022, one customer accounted for 100% of accounts receivable.~~risk

~~During~~Financial instruments which potentially subject the ~~three~~Company ~~months~~to ~~ended~~credit ~~September~~risks ~~30,~~consist ~~2023, one~~primarily ~~customer~~of ~~accounted~~cash ~~for~~and ~~100%~~cash ofequivalents, ~~revenues~~and accounts receivable. ~~During~~Cash ~~the~~and ~~three~~cash ~~months~~equivalents ~~ended~~are ~~September~~held in ~~30,~~United ~~2022,~~States nofinancial ~~customer~~institutions. ~~accounted~~At ~~for~~times ~~more~~such ~~than~~amounts ~~10% of~~may ~~revenue~~exceed federally insured limits.

During the nine months ended September 30, 2023, one customer accounted for approximately 93% of revenues. During the nine months ended September 30, 2022, four customers accounted for more than 10% of revenue, at 60%, 14%, 14%, and 12%, for a total of 100%.

Stock-based compensation

We account for our stock-based compensation under ASC 718 “Compensation - Stock Compensation” using the fair value- based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the shorter of the service period or the vesting period of the stock-based compensation. This guidance establishes standards for the accounting for transactions in which an entity exchanges it equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments. The Company estimates the fair value of each stock option at the grant date by using the Black-Scholes option pricing model. Determining the fair value of stock-based compensation at the grant date under this model requires judgment, including estimating volatility, employee stock option exercise behaviors and forfeiture rates. The assumptions used in calculating the fair value of stock-based compensation represent the Company’s best estimates, but these estimates involve inherent uncertainties and the application of management judgment.

Recently ~~issued~~Issued ~~accounting~~Accounting ~~pronouncements~~Pronouncements

~~The~~We ~~Company~~have ~~has~~reviewed ~~implemented~~the ~~all~~FASB ~~new~~issued ~~accounting~~Accounting Standards ~~pronouncements~~Update ~~that~~(“ASU”) ~~are~~accounting inpronouncements ~~effect.~~and ~~These~~interpretations ~~pronouncements~~thereof ~~did~~that ~~not~~ have ~~any~~effectiveness ~~material~~dates ~~impact~~during on the ~~financial~~periods ~~statements~~reported and ~~unless~~in ~~otherwise disclosed,~~future ~~and~~periods. ~~the~~The Company ~~does~~has ~~not~~carefully ~~believe~~considered ~~that~~the ~~there~~new ~~are~~pronouncements ~~any~~that ~~other~~alter ~~new~~previous generally accepted accounting ~~pronouncements~~principles and does not believe that ~~have~~any ~~been~~new ~~issued~~or ~~that~~modified ~~might~~principles will have a material impact on ~~its~~the corporation’s reported financial position or ~~results~~operations in the near term. The applicability of ~~operations~~any standard is subject to the formal review of our financial management and certain standards are under consideration.

Change in ~~accounting~~account principle

Commencing inwith the second quarter of 2022, the Company prospectively changed its accounting treatment for securities that contain predominantly, fixed rate conversion features by recording the derivative feature as a put premium on stock settled debt. See Note 7 for further discussion. The ~~Company~~company believes this change in in accounting principle is preferable as it applies a more consistent method of accounting for convertible notes that contain similar ~~conversion~~ ~~features. This accounting change resulted in a gain on new methodology for accounting for debt~~ conversion features ~~of $27,856 on the consolidated statement of operations for the nine months ended September 30, 2022~~.

NOTE 3 – GOING CONCERN

The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles which contemplate continuation of the Company as a going-concern basis. The going concern basis assumes that assets are realized, and liabilities are extinguished in the ordinary course of business at amounts disclosed in the consolidated financial statements. The Company has incurred recurring losses from operations. The Company has an accumulated deficit of approximately $12.23 million. The company historically has had negative cash flow from operations. The Company’s ability to continue as a going concern depends upon its ability to obtain adequate funding to support its operations through continuing investments of debt and/or equity by qualified investors/creditors, internally generated working capital and monetization of intellectual property assets. These factors raise substantial doubt about the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Management is currently pursuing a business strategy which includes raising the necessary funds to finance the Company’s development and marketing efforts.

NOTE 4 – BUSINESS COMBINATIONS

Interview Mastery Asset Purchase

On December 16, 2022, the Company entered into an Asset Purchase Agreement (the “APA”) with a related party, Interview Mastery Corporation (“Interview Mastery”), a Delaware corporation, by and through Michael R. Neece (“Neece”), the Company’s Chief Product Officer, and Caseridus, Inc. Under the terms of the APA, the Company will pay the purchase price through the issuance of 1,000,000,000 ~~shares~~(pre-reverse split) shares of the Company’s common stock to the stockholders of Interview Mastery, valued at the stock price of $0.0002 on the acquisition date, that vest immediately for all of the business assets of Interview Mastery. An additional 1,000,000,000 ~~shares~~(pre-reverse split) shares of Company common stock will be issued as compensation in consideration of Neece’s employment with the Company which shall vest over a four (4) year period during which 250,000,000 (pre-reverse split) shares will vest on the first-year anniversary of Neece’s employment, followed by vesting in increments of 62,500,000 shares per quarter (3-month period) thereafter until the full amount is vested and all of which shall be contingent upon Neece’s continual employment with the Company. These shares were valued using the share price of $0.0002 at the date of acquisition, and they will be expensed as stock-based compensation based on the vesting terms contingent upon continual employment of Neece. In connection with the APA, the Company ~~shall~~created ~~create~~ a new board seat and ~~offer~~offered ~~such~~this seat to Neece who was ~~will be~~ formally invited to join the Company’s Board of Directors.

The acquisition was accounted for as a business combination in accordance with the acquisition method under the guidance in ASC 805-10 and 805-20. This business combination was accounted for as a related party acquisition, as Neece is the chief product officer of the Company. Accordingly, the total purchase consideration was allocated to net assets acquired based on their respective historical costs. The assets acquired, and liabilities assumed, if any, in a business purchase combination be recognized at their historical costs as of the acquisition date.

Accordingly, the total purchase consideration was allocated to net assets acquired based on their respective historical costs. The assets acquired, and liabilities assumed, if any, in a business purchase combination be recognized at their historical costs as of the acquisition date.

The final allocation of the purchase price in connection with the Interview Mastery acquisition was calculated as follows:

Description	Fair Value		Weighted Average Useful Life (Years)
Cash	$	1,633
Prepaid expenses		997
Loss on acquisition – related party		197,370
	$	200,000

Total acquisition costs incurred were $58,092 recorded as a component of General and administrative expenses. As a result of the business combination, the Company recognized a related party loss of $197,370 which ~~was~~is included in general and administrative expenses on the consolidated statements of operations during the year ended December 31, 2022.

~~The~~Pro ~~approximate~~Forma revenue and net loss for the acquired business as a standalone entity per ASC 805 from January 1, 2021 to December 31, 2021 was $14,692 and $21,862, respectively, and from January 1, 2022 to December 17, 2022 was $13,059 and $15,279, respectively.Information

The results of operations of Interview Mastery will be included in the Company’s consolidated financial statements as of the date of acquisition through the current period end. The following supplemental pro-forma financial information approximate combined financial information assumes that the acquisition had occurred at the beginning of the years ended December 31, 2022 and 2021:

	December 31,			December 31,
	2022			2021
Revenue	$	198,982		$	216,367
Net Loss	$	(4,595,717	)	$	(287,779	)
Earnings (Loss) per common share, basic and diluted	$	-		$	(0.02	)

NOTE 5 – LOANS PAYABLE

~~The~~As ~~loan~~a ~~payable~~result ~~balances~~of ~~are~~the reverse merger that occurred on May 4, 2022, as ~~follows:~~discussed in Note 1, the Company assumed Loans 1 through 5 on the table below from Cruzani.

	Rate			September 30, 2023		December 31, 2022
Loan 1		1	%	$	27,000	$	27,000
Loan 2		1	%		3,000		3,000
Loan 3		8	%		64,000		64,000
Loan 4		8	%		160,000		160,500
Loan 5		3.75	%		309,500		309,500
Total				$	564,000	$	564,000

The Cruzani loan payable balances are as follows:

Loans 1 through 5 are past due as of the issuance of these financial statements and are accordingly classified as current liabilities.

	Rate			March 31, 2024		December 31, 2023
Loan 1		1	%	$	42,000	$	27,000
Loan 2		1	%		3,000		3,000
Loan 3		8	%		64,000		64,000
Loan 4		8	%		160,500		160,500
Loan 5		3.75	%		-		-
Total				$	269,500	$	254,500

Annual maturities of the Cruzani notes payable are as follows:

For the year ending	Amount
December 31, 2024		6,807
December 31, 2025		7,066
December 31, 2026		7,336
December 31, 2027		7,616
Thereafter		240,675
Total payments	$	269,500

Loans 1 through 5 are past due as of the issuance of these financial statements.

Loan 1) On May 30, 2013, and August 12, 2013, Cruzani received advances from a director for $2,000 and $25,000, respectively. On August 12, 2013, the Company entered into an unsecured, non-guaranteed, demand loan agreement with the director for $27,000. The loan bears interest at 1% per annum compounded monthly.

Loan 2) On February 27, 2014, and March 19, 2015, Cruzani received advances from a director of $6,000, and $10,200, respectively. During the year ended December 31, 2015, the Company repaid $13,200. The advances are unsecured, due on demand and bears interest at 1% per annum compounded and calculated monthly.

Loan 3) On ~~May~~September 3018, ~~2013~~2014, ~~and~~May ~~August 12~~29, ~~2013~~2015, ~~Cruzani received~~July ~~advances~~3, ~~from~~2015, aDecember ~~director for $~~2,~~000 and~~ ~~$25~~2015,~~000,~~ ~~respectively.~~and OnJanuary ~~August 12~~4, ~~2013~~2016, ~~the~~Cruzani ~~Company~~ entered into an unsecured, non-guaranteed, ~~demand~~ loan ~~agreement~~agreements ~~with~~pursuant to which the Company ~~director~~received ~~for~~proceeds of $2735,000, $4,000, $5,000, $22,000, and $45,000, respectively. The ~~loan~~loans ~~bears~~bear interest at 18% per annum compounded ~~monthly~~annually and are due 1 year after the date of issuance.

Loan 24) On December 4, 2014, January 29, 2015, August 12, 2015, August 21, 2015, September 1, 2015, September 15, 2015, November 13, 2015, and December 23, 2015, Cruzani issued unsecured notes payable of $20,000, $20,000, $20,000, $25,000, $40,000, $25,000, $30,000 and $10,000, respectively, to a significant shareholder. The notes bear interest at an annual rate of 8% per annum, are uncollateralized, and due 1 year after the date of issuance.

Loan 5) Entities negatively impacted by the coronavirus (“COVID-19”) pandemic were eligible to apply for loans sponsored by the United States Small Business Administration (“SBA”) Economic Injury Disaster Loan (“EIDL Loan”) program. On ~~February~~July 2715, ~~2014~~2020, ~~and~~the ~~March~~Company ~~19,~~received ~~2015~~cash proceeds of $40,400 ~~Cruzani~~under ~~received~~this ~~advances~~program. ~~from~~In aaddition, ~~director~~in ofJuly 2020, the Company received $6,000 from the SBA as a COVID-19 Economic Injury Disaster Loan Advance (the “EIDL Advance”). The proceeds can be used to fund payroll, healthcare benefits, rent and ~~$10~~other qualifying expenses,~~200,~~ ~~respectively~~and the loan is not subject to a loan forgiveness provision. ~~During~~The standard EIDL Loan repayment terms include interest accruing at 3.75% per annum effective July 15, 2020; the payment schedule contains a one-year ~~ended~~deferral period on initial principal and interest payments; the loan term is thirty years; and there is no prepayment penalty or fees. The Company pledged all assets of the Company as collateral for the loan. As of December 31, ~~2015~~2021, the ~~Company~~amounts ~~repaid~~outstanding totaled $1340,~~200~~400, and was classified as part of notes payable on the consolidated balance sheet. Additionally, the Company entered into a security agreement with the SBA in which this promissory note is collateralized ~~The~~by ~~advances~~all ~~are~~tangible ~~unsecured~~and intangible assets of the Company. On January 6, ~~due~~2021, onthe ~~demand~~SBA ~~and~~announced ~~bears~~a ~~interest~~one-year ~~at 1%~~extension ~~per~~of ~~annum~~the ~~compounded~~deferral period for loans that commenced in 2020 delaying payments of principal and ~~calculated~~interest ~~monthly~~to July 2022. Pursuant to an SBA Procedural Notice in December 2020, the EIDL Advance was forgiven. The Company has recognized the entire EIDL Advance amount of $6,000 as grant income, which is included in other income (expense) in the consolidated statement of operations for the year ended December 31, 2021.

In February 2022, the Company agreed to the first and second modifications of the EIDL Loan. 3The EIDL was modified to include additional borrowings of $269,200, which were received in full in February 2022. Periodic monthly payments have increased to $1,556 in the first modification, and reduced to $1,506 in the second modification. Additionally, the Company entered into an amended security agreement with the SBA in which this promissory note, and the modifications, is collateralized by all tangible and intangible assets of the Company. The balance of the EIDL loan balance at March 31, 2024, and December 31, 2023 $193,202 and $193,202, respectively.

On September 18, 2014, May 29, 2015, July 3, 2015, December 2, 2015, and January 4, 2016, Cruzani entered into unsecured, non-guaranteed loan agreements pursuant to which the Company received proceeds of $35,000, $4,000, $5,000, $22,000, and $45,000, respectively. The loans bear interest at 8% per annum compounded annually and are due 1 year after the date of issuance.

Loan 4

On December 4, 2014, January 29, 2015, August 12, 2015, August 21, 2015, September 1, 2015, September 15, 2015, November 13, 2015, and December 23, 2015, Cruzani issued unsecured notes payable of $20,000, $20,000, $20,000, $25,000, $40,000, $25,000, $30,000 and $10,000, respectively, to a significant shareholder. The notes bear interest at an annual rate of 8% per annum, are uncollateralized, and due 1 year after the date of issuance.

Loan 5

Entities negatively impacted by the coronavirus (“COVID-19”) pandemic were eligible to apply for loans sponsored by the United States Small Business Administration (“SBA”) Economic Injury Disaster Loan (“EIDL Loan”) program. On July 15, 2020, the Company received cash proceeds of $40,400 under this program. In addition, in July 2020, the Company received $6,000 from the SBA as a COVID-19 Economic Injury Disaster Loan Advance (the “EIDL Advance”). The proceeds can be used to fund payroll, healthcare benefits, rent and other qualifying expenses, and the loan is not subject to a loan forgiveness provision. The standard EIDL Loan repayment terms include interest accruing at 3.75% per annum effective July 15, 2020; the payment schedule contains a one-year deferral period on initial principal and interest payments; the loan term is thirty years; and there is no prepayment penalty or fees. The Company pledged all assets of the Company as collateral for the loan. As of December 31, 2021, the amounts outstanding totaled $40,400, and was classified as part of notes payable on the consolidated balance sheet. Additionally, the Company entered into a security agreement with the SBA in which this promissory note is collateralized by all tangible and intangible assets of the Company. On January 6, 2021, the SBA announced a one-year extension of the deferral period for loans that commenced in 2020 delaying payments of principal and interest to July 2022. Pursuant to an SBA Procedural Notice in December 2020, the EIDL Advance was forgiven. The Company has recognized the entire EIDL Advance amount of $6,000 as grant income, which is included in other income (expense) in the consolidated statement of operations for the year ended December 31, 2021.

NOTE 6 – CONVERTIBLE NOTES

The following table summarizes the convertible notes as of ~~September~~March 3031, ~~2023~~2024, and December 31, ~~2022~~2023:

Creditor	Date Issued		Interest Rate				Maturity Date	September 30, 2023			December 31, 2022
								Put Premium
Travel Data Solutions, Inc. (1)	18-Nov-17			10	%		30-Nov-19	$	100,000		$	100,000
	March 31,				December 31,			On Stock
Travel Data Solutions, Inc. (2)	18-Jan-19			10	%		31-Jan-20		25,000			25,000
Creditor	2024				2023			Settled Debt
Third Party (3)	07-Jul-20			10	%		07-Jul-21		84,681			84,681
Frondeur	$	30,000			$	123,793		$	30,000
Trillium Partners, LP (4)	15-Jun-22			12	%		15-Jun-23		-			165,000
Kings Wharf		42,200				42,200			-
Trillium Partners, LP (4)	05-Aug-22			12	%		28-Jun-23		-			110,000
Diagonal Lending		117,000				117,000			-
Frondeur Partners LLC (5)	01-Aug-22			10	%		28-Feb-23		-			50,000
Trillium		-				-			30,000
Frondeur Partners LLC (5)	01-Oct-22			10	%		31-Jul-23		-			50,000
Matterhorn		-				8,454			-
Trillium Partners, LP (6)	19-Oct-22			8	%		09-Oct-23		275,000			275,000
Travel Data Solutions		-				125,000			-
King Wharf Opportunities Fund (7)	19-Oct-22			8	%		09-Oct-23		275,000			275,000
Third Party *		236,960				230,232			176,570
Trillium Partners, LP (4)	21-Oct-22			12	%		21-Oct-23		11,000			11,000
Total		426,160				646,679			236,570
Trillium Partners, LP (4)	06-Dec-22			10	%		30-Nov-23		17,000			17,000
Less: Debt discount		(236,570	)			(206,570	)
Frondeur Partners LLC (5)	01-Nov-22			10	%		31-Aug-23		-			25,000
Total Convertible notes payable	$	189,590			$	440,109
Frondeur Partners LLC (5)	01-Dec-22			10	%		30-Sep-23		10,000			10,000
Frondeur Partners LLC (5)	01-Jan-22			10	%		31-Oct-23		10,000			-
Frondeur Partners LLC (5)	01-Feb-23			12	%		30-Nov-23		10,000			-
Frondeur Partners LLC (5)	01-Mar-23			12	%		31-Dec-23		10,000			-
Trillium Partners, LP (4)	31-Mar-23			10	%		31-Dec-23		38,000			-
Frondeur Partners LLC (5)	01-Apr-23			12	%		31-Jan-24		10,000			-
Frondeur Partners LLC (5)	01-May-23			12	%		29-Feb-24		10,000			-
Frondeur Partners LLC (5)	01-Jun-23			12	%		31-Mar-24		10,000			-
Frondeur Partners LLC (5)	01-Jul-23			12	%		31-May-24		10,000			-
Trillium Partners, LP (4)	12-Jul-23			12	%		30-Apr-24		20,000			-
Trillium Partners, LP (4)	26-Jul-23			12	%		30-Apr-24		10,000			-
Frondeur Partners LLC (5)	1-Aug-23			12	%		30-Jun-24		10,000			-
Matterhorn Partners LLC (8)	15-Aug-23			12	%		30-Jun-24		21,000			-
Frondeur Partners LLC (5)	1-Sep-23			12	%		31-Jul-24		10,000			-
Total								$	976,681		$	1,197,681
Less: debt discount									(80,257	)		(528,100	)
Convertible notes payable, total									896,425			669,581

1) On November 18, 2017, Cruzani entered into a convertible promissory note for $25,000 with Travel Data Solutions, Inc., pursuant to which the Company received proceeds of $25,000. The notes are convertible at any time after September 13, 2018 at a mutually agreed upon conversion price, bearing interest rate at 10% per annum and due on November 30, 2019. During January and February 2018, the Company received an additional $75,000 under the same terms as the previously issued convertible promissory note. As of September 30, 2023 and December 31, 2022, $100,000 remains outstanding.

2)Frondeur On January 18, 2019, Cruzani executed a promissory note with Travel Data Solutions LLC for $35,000, of which it has received $25,000. The note bears interest at 10% and matures on January 31, 2020. The specific terms of conversion are still being negotiated. Commencing on January 31, 2019 and on the last day of each month thereafter, the Company shall pay to the Holder Three Thousand Two Hundred Eight dollars and Thirty-Three cents ($3,208.33) of which Two Thousand Nine Hundred Sixteen Dollars and Sixty-Six cents ($2,916.66) represents payment towards the outstanding Principal Amount and Two Hundred Nineteen Dollars and Sixty-Six cents ($219.66) represents accrued interest thereon. As of September 30, 2023 and December 31, 2022, $25,000 remains outstanding.

3)Between OnJune ~~July~~1, 72022 and December 1, ~~2020~~2022, the Company ~~issued~~entered ainto ~~$84,681~~several convertible ~~promissory~~notes ~~note~~with toFrondeur ~~a third party in exchange for $84~~Partners,~~681.~~ ~~The~~LLC ~~Convertible~~bearing ~~Note bears~~ interest at 10% per annum. ~~All~~and ~~unpaid~~totaling ~~principal~~$160,000. ~~and~~These convertible ~~accrued~~notes ~~interest~~are ~~under~~convertible ~~the~~between ~~Convertible~~50% ~~Note~~and ~~will~~70% beof ~~due~~the ~~and~~lowest ~~payable~~close inbid ~~full~~price ~~one~~of ~~year~~the ~~from~~Company’s ~~issuance.~~stock price ~~After~~for ~~six~~a ~~months~~twenty day ~~from~~period. These ~~the~~convertible ~~issuance~~notes ~~date,~~were ~~the~~accounted ~~Holder~~for ~~may~~as ~~elect~~stock tosettled ~~convert~~debt ~~into~~in ~~that~~accordance ~~number~~with ofASC ~~shares~~480 of- ~~common~~“Distinguishing Liabilities ~~stock~~from ~~equal~~Equity”, toresulting ~~the~~in ~~quotient~~put ~~obtained~~premiums byon ~~dividing~~stock ~~the~~settled ~~outstanding~~debt ~~principal~~being ~~balance~~recognized. ~~and~~See ~~unpaid~~Note ~~accrued~~7. ~~interest~~During ~~under~~the ~~this~~years ~~Note~~ended byDecember 31, 2023 and 2022,the ~~amount~~lender ~~equal~~opted to ~~the~~convert ~~anticipate~~certain ~~public~~portions ~~market~~of ~~price~~the note into shares of the Company’s common stock ~~multiplied by fifty percent (50%)~~. ~~This~~Through ~~convertible~~March 31, ~~note~~2024, ~~was~~the ~~accounted~~Company ~~for~~issued asthree ~~stock~~convertible ~~settled~~notes. ~~debt~~The intotal ~~accordance~~principal ~~with~~amount ~~ASC~~of ~~480~~these -notes ~~“Distinguishing~~is ~~Liabilities from Equity”~~$30,000. ~~resulting~~They inbear ~~put~~interest ~~premiums~~at on12% and ~~stock~~are ~~settled~~due ~~debt~~in ~~being~~full ~~recognized.~~at ~~See~~October ~~Note~~31, 7.2024, AsNovember ~~of September~~ 30, ~~2023~~2024 and December 31, ~~2022~~2024, ~~this~~respectively. ~~convertible~~Due ~~note~~to isthese inconversions, ~~default and~~ the remaining principal balances at March 31, 2024, and ~~accrued~~December ~~interest~~31, ~~balance~~2023, ~~remain~~was ~~outstanding~~$30,000 and $123,793, respectively.

Between November 1, 2021 and May 1, 2022, Cruzani entered into several convertible notes with Frondeur Partners, LLC bearing interest at 10% per annum and totaling $175,000. These convertible notes were convertible at 70% of the lowest close bid price of the Company’s stock price for a twenty day period. These convertible notes were accounted for as stock settled debt in accordance with ASC 480 - “Distinguishing Liabilities from Equity”, resulting in put premiums on stock settled debt being recognized. See Note 7. As of December 31, 2022, these convertible notes were converted into shares of the Company’s common stock.

During the three months ended March 31, 2024, the Company issued three additional convertible notes to Fondeur. The aggregate principal amount of these notes is $30,000, and the notes are dated January 1, 2024 ($10,000), February 1, 2024 ($10,000) and March 1, 2024 ($10,000). They bear interest at 12% and are due in full at October 31, 2024, November 30, 2024 and December 31, 2024, respectively. During Due to these conversions, the remaining principal balances at March 31, 2024, and December 31, 2023, was $30,000 and $123,793, respectively. The Company granted 150,000 warrants to purchase 150,000 shares of the Company’s common stock with these convertible notes. These warrants have an exercise price of $0.0001 and a term of five years.

Kings Wharf

On October 19, 2022, the Company entered into a convertible note with King Wharf Opportunities Fund bearing interest at 8% totaling $275,000. The note included an original issue discount of $25,000. This convertible note is convertible at the lesser of $0.0001 or 50% of the lowest trading price of the Company’s stock price for a thirty day period. The embedded conversion option of the convertible note contains conversion features that qualify for embedded derivative classification as a result of variable conversion price features, which is not a fixed discount rate. See Note 8. This convertible note is fully guaranteed by the Company’s Chief Executive Officer, Eddie Aizman, and President, Michael Lakshin. Additionally, on October 19, 2022, both Mr., Aizman and Mr. Lakshin, entered into pledge agreements in which they each have agreed to secure the Company’s payment obligations to the lender with a guaranty and a pledge of 163,461 shares of Series G preferred stock of the Company, for a total of 326,922 shares of Series G Preferred Stock. During the years ended December 31, 2023 and 2022, the lender opted to convert certain portions of the note into shares of the Company’s common stock. Due to these conversions, the remaining principal balances at March 31, 2024, and December 31, 2023, was $42,200 and $42,200, respectively.

Diagonal Lending

November 10, 2023, the Company entered into a convertible note with Diagonal Lending bearing interest at 10% totaling $77,000. This convertible note is convertible at the lesser of $0.0001 or 61% of the lowest trading price of the Company’s stock price for a thirty-day period. The embedded conversion option of the convertible note contains conversion features that quality for embedded derivative classification as a result of variable conversion price features, which is not a fixed discount rate. The outstanding remaining principal balances at March 31, 2024, and December 31, 2023, was $77,000 and $77,000, respectively.

December 12, 2023, the Company entered into a convertible note with Diagonal Lending bearing interest at 10% totaling $40,000. This convertible note is convertible at the lesser of $0.0001 or 61% of the lowest trading price of the Company’s stock price for a thirty-day period. The embedded conversion option of the convertible note contains conversion features that quality for embedded derivative classification as a result of variable conversion price features, which is not a fixed discount rate. The outstanding remaining principal balances at March 31, 2024, and December 31, 2023, was $40,000 and $40,000, respectively.

Trillium

Between May 25, 2021 and July 6, 2021, Cruzani entered into two convertible notes with Trillium Partners, LP bearing interest at 10% per annum and totaling $44,000. These convertible notes were convertible at a fixed price of $0.0001. During the years ended December 31, 2023 and 2022, the lender opted to convert certain portions of the note into shares of the Company’s common stock. Due to these conversions, the remaining principal balances at March 31, 2024, and December 31, 2023, was $0 and $0.

Between June 1, 2022 and December 6, 2022, the Company entered into several convertible notes with Trillium Partners, LP bearing interest between 10% and 12% per annum and totaling $332,800. These convertible notes are convertible at a fixed price between $0.0001 and $0.0002. During the years ended December 31, 2023 and 2022, the lender opted to convert certain portions of the note into shares of the Company’s common stock. Due to these conversions, the remaining principal balances at March 31, 2024, and December 31, 2023, was $0 and $0, respectely.

On October 19, 2022, the Company entered into a convertible note with Trillium Partners, LP bearing interest at 8% totaling $275,000. The note included an original issue discount of $25,000. This convertible note is convertible at the lesser of $0.0001 or 50% of the lowest trading price of the Company’s stock price for a thirty day period. The embedded conversion option of the convertible note contains conversion features that qualify for embedded derivative classification as a result of variable conversion price features, which is not a fixed discount rate. See Note 8. This convertible note is fully guaranteed by the Company’s Chief Executive Officer, Eddie Aizman, and President, Michael Lakshin. Additionally, on October 19, 2022, both Mr., Aizman and Mr. Lakshin, entered into pledge agreements in which they each have agreed to secure the Company’s payment obligations to the lender with a guaranty and a pledge of 163,461 shares of Series G preferred stock of the Company, for a total of 326,922 shares of Series G Preferred Stock. During the years ended December 31, 2023 and 2022, the lender opted to convert certain portions of the note into shares of the Company’s common stock. Due to these conversions, the remaining principal balances at March 31, 2024, and December 31, 2023, was $0 and $0, respectively.

4) Between June 15, 2022 and September 30, 2023, the Company entered into several convertible notes with Trillium Partners, LP bearing interest between 10% and 12% per annum and totaling $414,800. These convertible notes are convertible at a fixed price between $0.0001 and $0.0002. As of September 30, 2023 and December 31, 2022, $444,800 and $29,800 of these convertible notes were converted into shares of the Company’s common stock, respectively, and $96,000 and $303,000 are outstanding, respectively.Matterhorn

5)On ~~Between~~August ~~June 1~~15, ~~2022 and September 30,~~ 2023, the Company entered into ~~several~~ a convertible ~~notes~~note with ~~Frondeur~~Matterhorn Partners, LLC bearing interest at 1012% ~~per~~totaling ~~annum~~$25,000. ~~and~~The ~~totaling~~note included an original issue discount of $~~395~~4,000. ~~These~~This convertible ~~notes~~note ~~are~~is convertible ~~between~~at ~~50%~~the ~~and~~lesser 70of $0.0001 or 50% of the lowest ~~close~~trading ~~bid~~ price of the Company’s stock price for a ~~twenty~~ thirty-day period. ~~These~~The ~~convertible~~embedded ~~notes~~conversion ~~were~~option ~~accounted~~of ~~for~~the asconvertible ~~stock~~note ~~settled~~contains ~~debt~~conversion infeatures ~~accordance~~that ~~with~~quality ~~ASC~~for ~~480~~embedded derivative -classification ~~“Distinguishing~~as ~~Liabilities~~a ~~from~~result ~~Equity”,~~of ~~resulting~~variable inconversion ~~put~~price ~~premiums~~features, onwhich ~~stock~~is ~~settled~~not ~~debt~~a ~~being~~fixed ~~recognized~~discount rate. ~~See~~This ~~Note~~convertible 7.note is Asfully ofguaranteed ~~September~~by 30the Company’s Chief Executive Officer, ~~2023~~Eddie Aizman and President, Michael Lakshin. During the years ended December 31, 2023 and 2022, ~~$260,000~~the ~~and~~lender ~~$25,000~~opted ofto ~~these~~convert ~~convertible~~certain ~~notes~~portions ~~were~~of ~~converted~~the note into shares of the Company’s common stock. Due to these conversions, ~~and~~the asremaining ofprincipal ~~September~~balances 30at March 31, ~~2023~~2024, and December 31, ~~2022~~2023, was $~~60,000~~ 0 and $~~135~~8,~~000~~454, ~~of principal remains outstanding~~respectively.

6)Travel OnData October 19, 2022, the Company entered into a convertible note with Trillium Partners, LP bearing interest at 8% totaling $275,000. The note included an original issue discount of $25,000. This convertible note is convertible at the lesser of $0.0001 or 50% of the lowest trading price of the Company’s stock price for a thirty-day period. The embedded conversion option of the convertible note contains conversion features that qualify for embedded derivative classification as a result of variable conversion price features, which is not a fixed discount rate. See Note 8. This convertible note is fully guaranteed by the Company’s Chief Executive Officer, Eddie Aizman, and President, Michael Lakshin. Additionally, on October 19, 2022, both Mr., Aizman and Mr. Lakshin, entered into pledge agreements in which they each have agreed to secure the Company’s payment obligations to the lender with a guaranty and a pledge of 163,461 shares of Series G preferred stock of the Company, for a total of 326,922 shares of Series G Preferred Stock. As of September 30, 2023 and December 31, 2022, the outstanding principal balance totaled $275,000.Solutions

7) On ~~October~~November 1918, ~~2022~~2017, ~~the~~Cruzani ~~Company~~ entered into a convertible promissory note ~~with~~for ~~King Wharf Opportunities Fund bearing interest at 8% totaling~~ $~~275~~25,000. ~~The~~with ~~note~~Travel ~~included~~Data ~~an original issue discount of $25~~Solutions,~~000.~~ ~~This convertible note is convertible at the lesser of $0~~Inc.~~0001~~, orpursuant ~~50%~~to ofwhich the ~~lowest~~Company ~~trading~~received ~~price~~proceeds of ~~the Company’s stock price for a thirty-day period~~$25,000. The ~~embedded~~notes ~~conversion option of the~~ are convertible ~~note~~at ~~contains~~any ~~conversion~~time ~~features~~after ~~that~~September ~~qualify~~13, ~~for~~2018 ~~embedded~~at ~~derivative classification as~~ a ~~result~~mutually ofagree ~~variable~~upon conversion price ~~features~~, ~~which~~bearing isinterest ~~not a fixed discount~~ rate. ~~See~~at ~~Note~~10% 8.per ~~This~~annum ~~convertible note is fully guaranteed by the Company’s Chief Executive Officer, Eddie Aizman,~~ and due ~~President, Michael Lakshin. Additionally,~~ on ~~October~~November 1930, ~~2022, both Mr~~2019. ~~Aizman~~During January and ~~Mr.~~February ~~Lakshin~~2018, ~~entered~~the ~~into~~Company ~~pledge~~received ~~agreements~~an inadditional ~~which~~$75,000 ~~they~~under ~~each~~the ~~have~~same ~~agreed~~terms toas ~~secure~~ the ~~Company’s~~previously issued ~~payment~~convertible ~~obligations~~promissory tonote. During the ~~lender~~year ~~with~~ended aDecember ~~guaranty~~31, ~~and a pledge of 163~~2023,~~461~~ ~~shares~~the ofbalance ~~Series G preferred stock~~ of the ~~Company,~~note ~~for~~was aconverted ~~total~~into ~~of 326,922~~ shares of ~~Series~~the Company’s Gcommon ~~Preferred Stock~~stock. As of ~~September~~March 3031, ~~2023~~2024, and December 31, ~~2022~~2023, the outstanding ~~principal~~ balance ~~totaled~~was $~~275~~ 0 and $125,000, respectively.

8)Third On August 15, 2023, the Company entered into a convertible note with Matterhorn Partners LLC bearing interest at 12% totaling $25,000. The note included an original issue discount of $4,000. This convertible note is convertible at the lesser of $0.0001 or 50% of the lowest trading price of the Company’s stock price for a thirty-day period. The embedded conversion option of the convertible note contains conversion features that quality for embedded derivative classification as a result of variable conversion price features, which is not a fixed discount rate. See Note 8. This convertible note is fully guaranteed by the Company’s Chief Executive Officer, Eddie Aizman and President, Michael Lakshin.Party

As a result of the reverse merger that occurred on May 4, 2022, as discussed in Note 1, the Company assumed convertible notes from Cruzani (1-3 below). Convertible debt outstanding during the three months ended March 31, 2024, and the year ended December 31, 2023, consist of the following:

Between May 20, 2020 and October 1, 2021, Cruzani entered into several convertible notes with Livingston Asset Management bearing interest at 10% per annum and totaling $331,600. These convertible notes were convertible at 70% of the lowest close bid price of the Company’s stock price for a twenty day period. These convertible notes were accounted for as stock settled debt in accordance with ASC 480 - “Distinguishing Liabilities from Equity”, resulting in put premiums on stock settled debt being recognized. As of December 31, 2022, these convertible notes were converted into shares of the Company’s common stock.

On November 17, 2021, Cruzani entered into a convertible note with Oscaleta Partners, LLC bearing interest at 10% per annum and totaling $11,000. This convertible note was convertible at 50% of the lowest close bid price of the Company’s stock price for a twenty day period. This convertible note was accounted for as stock settled debt in accordance with ASC 480 - “Distinguishing Liabilities from Equity”, resulting in a put premium on stock settled debt being recognized. As of December 31, 2022, the convertible note was converted into shares of the Company’s common stock.

On July 7, 2020, the Company issued a $84,681 convertible promissory note to a third party in exchange for $84,681. The Convertible Note bears interest at 10%, per annum. All unpaid principal and accrued interest under the Convertible Note will be due and payable in full one year from issuance. After six months from the issuance date, the Holder may elect to convert into that number of shares of common stock equal to the quotient obtained by dividing the outstanding principal balance and unpaid accrued interest under this Note by the amount equal to the anticipate public market price of the Company’s common stock multiplied by fifty percent (50%). This convertible note was accounted for as stock settled debt in accordance with ASC 480 - “Distinguishing Liabilities from Equity”, resulting in put premiums on stock settled debt being recognized. See Note 7. As of December 31, 2022, this convertible note is in default and the principal and accrued interest balance remain outstanding. During the year ended December 31, 2023, the Company had additional borrowings of $6,728. As of March 31, 2024, and December 31, 2023, the outstanding balance was $236,960 and $230,232, respectively

NOTE 7 – PUT PREMIUM ON STOCK SETTLED DEBT

~~When~~At the end of the quarter ended June 30, 2022, the Company ~~enters~~decided to adopt ASC 480- “Distinguishing Liabilities from Equity.” When they enter into convertible notes, ~~some~~ some of which contain, predominantly, fixed rate conversion features (See Note 57 for conversion terms), whereby the outstanding principal ~~and~~ and accrued interest may be converted by the holder, into common shares at a fixed discount to the market price of the common stock at ~~the~~ the time of conversion. This results in a fair value of the convertible note being equal to a fixed monetary amount. The Company records ~~the~~ the convertible note liability at its fixed monetary amount by measuring and recording a put premium on the consolidated balance sheets, as as applicable, on the note date with a charge to interest expense. ~~The put premiums are expensed on issuance of the debt with the liability released to additional paid in capital on conversion of the principal.~~

~~All~~The put premiums are ~~recorded~~expensed ason aissuance ~~liability~~of ~~as put premium on stock~~the ~~settled~~ debt onwith the ~~consolidated~~liability ~~balance~~released ~~sheets~~to ~~with~~additional apaid ~~charge~~in tocapital ~~interest~~on ~~expense~~conversion of the principal.

~~Put~~In previous years, the Company had recorded such items as derivative liabilities (See Note 8). Thus, there was a charge to put premium on stock settled debt byand ~~individual~~a ~~note~~decrease isto derivative liability for all convertible debt determined to have fixed rate conversion options. On a going-forward basis, all put premiums will be recorded as ~~follows:~~a liability as put premium on stock settled debt on the consolidated balance sheets with a charge to interest expense.

	Date Issued	Maturity Date	Note balance as of September 30, 2023			Discount Percentage			Put premium on stock settled debt
Travel Data Solutions, Inc.	18-Nov-17	30-Nov-19	$	100,000			0	%	$	-
Travel Data Solutions, Inc.	18-Jan-19	31-Jan-20		25,000			0	%		-
Third party	7-Jul-20	7-Jul-21		84,681			50	%		84,681
Trillium Partners, LP*	19-Oct-22	09-Oct-23		275,000			0	%		-
King Wharf Opportunities Fund*	19-Oct-22	09-Oct-23		275,000			0	%		-
Trillium Partners, LP	21-Oct-22	21-Oct-23		11,000			0	%		-
Trillium Partners, LP	06-Dec-22	30-Nov-23		17,000			0	%		-
Frondeur Partners LLC	01-Oct-22	31-Aug-23		25,000			50	%		-
Frondeur Partners LLC	01-Dec-22	30-Sep-23		10,000			50	%		10,000
Frondeur Partners LLC	01-Jan-23	31-Oct-23		10,000			50	%		10,000
Frondeur Partners LLC	01-Feb-23	30-Nov-23		10,000			50	%		10,000
Frondeur Partners LLC	01-Mar-23	31-Dec-23		10,000			50	%		10,000
Trillium Partners, LP	31-Mar-23	31-Dec-23		38,000			0	%		-
Frondeur Partners LLC	01-Apr-23	31-Jan-24		10,000			50	%		10,000
Frondeur Partners LLC	01-May-23	29-Feb-24		10,000			50	%		10,000
Frondeur Partners LLC	01-Jun-23	31-Mar-24		10,000			50	%		10,000
Frondeur Partners LLC	01-Jul-23	31-May-24		10,000			50	%		10,000
Trillium Partners, LP	12-Jul-23	30-Apr-24		20,000			0	%		-
Trillium Partners, LP	26-July-23	30-Apr-24		10,000			0	%		-
Frondeur Partners LLC	1-Aug-23	30-Jun-24		10,000			50	%		10,000
Matterhorn Partners LLC	15-Aug-23	30-Jun-24		21,000			50	%		21,000
Frondeur Partners LLC	1-Sep-23	31-Jul-24		10,000			50	%		10,000
Total				976,681						205,684
Less: debt discount				(80,257	)					-
Convertible notes payable, total			$	896,425					$	205,684

The company believes this change in accounting principles in preferable as it applies a more consistent method of accounting for convertible notes that contain similar conversion features. This accounting change resulted in a gain on new methodology for accounting for debt conversion features of $0 and $27,856 on the statement of operations for the years ended December 31, 2023 and December 31, 2022, respectively.

NOTE 8 – DERIVATIVE LIABILITIES

~~The~~Commencing ~~embedded~~with ~~conversion~~the ~~options~~second quarter of ~~certain~~2022, of the Company’s ~~convertible~~changed ~~debentures~~its ~~summarized~~accounting intreatment ~~Note~~for 5securities ~~contain variable conversion features~~ that ~~qualify~~contain ~~for~~predominantly, ~~embedded~~fixed ~~derivative classification~~rate ~~under ASC 815-15 Embedded Derivatives (See Note 5 for~~ conversion ~~terms).~~features ~~The~~by ~~fair~~recording ~~value~~the ~~of these liabilities is re-measured~~derivative atfeature ~~the end of every reporting period and the change in fair value is reported in the statement of operations~~ as a ~~gain~~put orpremium ~~loss~~ on ~~derivative financial~~stock ~~instruments~~settled debt.

The embedded conversion options of certain of the Company’s convertible debentures summarized in Note 6 contain variable conversion features that qualify for embedded derivative classification under ASC 815-15 Embedded Derivatives. The fair value of these liabilities is re-measured at the end of every reporting period and the change in fair value is reported in the statement of operations as a gain or loss on derivative financial instruments.

The table below sets forth a summary of changes in the fair value of the Company’s Level 3 financial liabilities:

	Total
Balance as of December 31, 2021	$	110,992
Change Due to Issuances		2,718,645
Transfer to put premium		(112,537	)
Change in fair value		(544,850	)
Balance as of December 31, 2022	$	2,172,250
Change Due to Issuances		~~129~~(4,~~929~~035,300	)
Transfer to put premium		~~(62~~651,~~500~~156	)
Change in fair value		~~149~~1,~~909~~645,712
Balance as of September 30, 2023	$	2,389,588
Balance as of December 31, 2023		433,818
Change in fair value		386,126
Balance as of March 31, 2024	$	819,944

The Company uses Level 3 inputs for its valuation methodology for its conversion option liabilities as their fair values were determined by using Black-Scholes options pricing model. The option-pricing model requires a number of assumptions, of which the most significant are share price, expected volatility and the expected option term (the time from the issuance date until the maturity date). The Company has historically not paid dividends and has no foreseeable plans to issue dividends. The risk-free interest rate is based on the yield from governmental zero-coupon bonds with an equivalent term. As, required, these are classified based on the lowest level of input that is significant to the fair value measurement.

The following table shows the assumptions used in the calculations of its derivatives:

	September 30, 2023		December 31, 2022
		March 31, 2024		December 31, 2023
Stock price	~~$ 0.0001- $0.0005~~	$0.0001 - $0.1500	~~$ 0.0002 - $0.0005~~	$0.0001 - $0.1500
Exercise price	~~$ 0.00003- $0.0001~~	$0.00003 - $0.2572	~~$ 0.00005 - $0.0001~~	$0.00003 - $0.2572
Contractual term (in years)	~~7.00 - 0.025~~	7.00 – 0.025	~~1.00 - 0.80~~	7.00 – 0.025
Volatility (annual)	~~174%- 460 %~~	174% - 2068%	~~441% - 443 %~~	174% - 2068%
Risk-free rate	~~4.41% - 5.55 %~~	4.41% - 5.57%	~~4.41% - 4.60 %~~	4.41% - 5.57%

NOTE 9 – ~~COMMON~~RELATED ~~STOCK~~PARTY TRANSACTIONS

~~The~~For ~~Company~~the ~~has~~three ~~been~~months ~~authorized~~ended toMarch ~~issue 40~~31,~~000,000 shares of~~ ~~common stock~~2024, ~~$0.00001 par value. Each share of issued~~ and ~~outstanding common stock shall entitle~~ the ~~holder~~year ~~thereof~~ended toDecember ~~fully participate~~31, ~~in all shareholder meetings~~2023, toexpenses ~~cast one vote~~of ~~on each matter with respect to which shareholders have the right to vote~~$9,693 and to$38,771 ~~share~~were ~~ratably~~incurred infor ~~all~~recruitment ~~dividends~~services ~~and~~by ~~other~~an ~~distributions~~entity ~~declared~~owned ~~and~~by ~~paid with respect to common stock~~Michael Neece, asChief ~~well~~Product ~~as in the net assets of the corporation upon liquidation or dissolution~~Officer.

AsPer ofthe ~~September~~agreement 30with Michael Neece, ~~2023~~a salary of $12,500 and a bonus of $4,167 was accrued for the year ended December 31, 2022, . For the ~~Company~~year ~~had~~ended ~~333~~December 31,~~609~~ 2023,~~842~~ an additional $150,000 in salary and ~~270~~a bonus of $50,~~497~~000 was accrued. For the three Months ended March 31,~~364 shares~~ of2024, ~~common~~and ~~stock~~additional ~~outstanding~~$37,500 ~~respectively~~in salary was accrued.

~~During~~On ~~the~~December ~~three~~16, ~~and~~2022, ~~nine~~Bowmo, ~~months~~Inc. ~~ended~~(the ~~September~~“Company”) ~~30,~~entered ~~2023,~~into an Asset Purchase Agreement (the ~~Company~~“APA”) ~~issued 9~~with a related party,~~198~~ Interview Mastery Corporation (“Interview Mastery”),~~068~~ a Delaware corporation, by and 63through Michael R. Neece (“Neece”) and Caseridus,~~112~~ Inc. Michael Neece,~~489~~ ~~shares~~the seller of ~~common~~Interview ~~stock.~~Mastery, ~~respectively~~is ~~for~~ the ~~extinguishment~~chief ofproduct ~~convertible debt~~officer asof ~~follows:~~ the Company.

Creditor	Date	Shares Issued		Principal Retired		Accrued Interest		Fees		Total
Frondeur Partners, LLC	17-Feb-23		11,230,946		50,000		2,740		3,415		56,155
Trillium Partners, LP	7-Mar-23		18,953,878		165,000		14,294		10,245		189,539
Trillium Partners, LP	17-Mar-23		12,289,007		110,000		9,475		3,415		122,890
Frondeur Partners, LLC	12-Apr-23		11,440,580		50,000		2,644		3,415		56,059
			53,914,411		375,000		29,152		20,490		424,642

Through March 31, 2024, the Company owed Eddie Aizman and Michael Lakshin compensation based on their employment agreements; the agreements provide for annual salaries of $180,000 and $200,000, respectively commencing on September 6, 2022. During the year ended December 31, 2022, salaries of $57,205 and $63,562, were accrued for Eddie Aizman and Michael Lakshin, respectively. During the three months ended March 31, 2024, and the year ended December 31, 2023, salaries of $180,000 and $200,000, were accrued for Eddie Aizman and Michael Lakshin, respectively on an annualized basis. As of March 31, 2024, the total due to Eddie Aizman and Michal Lakshin is $282,205 and $313,562, respectively.

On July 8, 2019, the Company executed an employment agreement with Conrad Huss. The agreement provides for a salary of $10,000 per month. As of March 31, 2024, no additional amounts have been credited to accrued compensation.

NOTE 10 – COMMON STOCK

The Company has been authorized to issue 40,000,000,000 shares of common stock, $0.00001 par value. Each share of issued and outstanding common stock shall entitle the holder thereof to fully participate in all shareholder meetings, to cast one vote on each matter with respect to which shareholders have the right to vote, and to share ratably in all dividends and other distributions declared and paid with respect to common stock, as well as in the net assets of the corporation upon liquidation or dissolution.

During the year ended December 31, 2022, the Company issued 18,094,721,962 (pre-reverse split) shares of common stock for the extinguishment of convertible debt.

During the year ended December 31, 2023, the Company issued 6,364,768,689 (post-reverse split) shares of common stock for the extinguishment of convertible debt.

During the three months ended March 31, 2024, the Company issued 56,020,716 shares of common stock for the extinguishment of convertible debt.

As of March 31, 2024, the Company had 109,541,546 shares of common stock outstanding.

Acquisition of Interview Mastery

As discussed in Note 4, on December 16, 2022, the Company acquired Interview Mastery at a purchase price of 101,000,000,000 (pre-reverse split) shares of the Company’s common stock, valued at $200,000 using the stock price on the acquisition date. As of ~~September~~March 3031, ~~2023~~2024 and December 31, ~~2022~~2023, these shares have not been issued and are recorded as a liability within accrued expenses on the ~~unaudited condensed~~ consolidated balance ~~sheets~~sheet.

Michael Neece employment agreement

On December 16, 2022, the Company entered into an employment agreement with Michael Neece, Chief Product Officer. Under the agreement, 101,000,000,000 (pre-reverse split) shares of Company common stock will be issued as compensation in consideration of Neece’s employment with the Company which shall vest over a four (4) year period during which 2250,~~500~~000,000 (pre-reverse split) shares will vest on the first-year anniversary of Neece’s employment, followed by vesting in increments of ~~625~~62,500,000 (pre-reverse split) shares per quarter (3-month period) thereafter until the full amount is vested and all of which shall be contingent upon Neece’s continual employment with the Company. These shares were valued using the share price of $0.0002 at the date of acquisition, and they will be expensed as stock-based compensation based on the vesting terms contingent upon continual employment of Neece. As of ~~September 30~~December 31, 2023, ~~none of these shares have vested,~~ and ~~the~~December ~~Company has recognized $29~~31,~~257~~ ~~and $85~~2022,~~885,~~ ~~respectively~~250,000 ~~of stock-based compensation within general~~ and ~~administrative~~250,000 ~~expenses~~shares onhave ~~the consolidated statement of operations during the three and nine months ended September 30~~vested, ~~2023~~ respectively.

NOTE 1011 – WARRANTS

In ~~2022, in~~ connection with the issuance of convertible notes ~~with Frondeur~~to ~~Partners, LLC (“Frondeur”), King Wharf Opportunities Fund, and~~ Trillium ~~Partners~~and Fondeur, ~~LP,~~ the Company ~~also~~ issued 5638,~~160~~650,000 post-reverse split) common stock purchase warrants to purchase 5638,~~160~~650,000 shares of the Company’s common stock pursuant to the terms therein as a commitment fee. During the three months ended March 31, 2024, the Company, in connection with the three additional notes issued to Fondeur, granted the issuance of an additional 150,000 warrants to purchase 150,000 shares of the Company’s common stock.

These warrants have an exercise price per share between $0.~~0025~~ 025- $0.~~0001~~001 the above and expire between five – and seven years. The aggregate fair value of the warrants, which was allocated against the debt proceeds totaled $~~619~~596,~~675~~927 based on the Black Scholes Merton pricing model using the following estimates: exercise price ranging from $0.~~00025~~ 0025 and $0.~~0025~~025, 2.50% - to 4.28% risk free rate, ~~256~~266.6174% - to 699.48% volatility and expected life of the warrants of 5 to 7 years. The fair value was credited to additional paid in capital and debited to debt discount to be amortized over the term of the loan.

A summary of the status of the Company’s outstanding stock warrants and changes during the periods is presented below:

	Shares available to purchase with warrants		Weighted Average Price		Weighted Average Remaining life
	Shares available to purchase with warrants*		Weighted Average Price		Weighted Average Remaining life
Outstanding, December 31, 2022		56,160,000	$	0.0001		6.09
Outstanding, December 31, 2023		38,650,000	$	0.001	$	6.54
Issued		7150,~~500,~~000	$	0.~~0001~~001		~~4.52~~-
Exercised		–-	$	–-		–-
Forfeited		–-	$	–-		–-
Expired		–-	$	–-		–-
Outstanding, September 30, 2023		63,660,000	$	0.0001		4.78
Outstanding, March 31, 2024		38,800,000	$	0.001	$	6.56
Exercisable, September 30, 2023		63,660,000	$	0.0001		4.78
Exercisable, March 31, 2024		38,800,000	$	0.001	$	6.56

*	Post reverse split shares

The Company uses Level 3 inputs for its valuation methodology for its conversion option liabilities as their fair values were determined by using the Binomial option pricing model based on various assumptions. The model incorporates the price of a share of the Company’s common stock (as quoted on the Over the Counter Bulletin Board), volatility, risk free rate, dividend rate and estimated life. Significant changes in any of these inputs in isolation would result in a significant change in the fair value measurement. As, required, these are classified based on the lowest level of input that is significant to the fair value measurement. The following table shows the assumptions used in the calculations:

Range of Exercise Prices		Number Outstanding December 31, 2023		~~Number Outstanding September 30, 2023~~		Weighted Average Remaining Contractual Life		~~Weighted Average Remaining Contractual Life~~		Weighted Average Exercise Price		~~Weighted Average Exercise Price~~
$	0.00025-0.0025				61,160,000				5.86 years			$	0.0001
$0.025-0.0010			38,800,000				6.56 years			$	0.001

NOTE 1112 – PREFERRED STOCK

Series AA and Super Convertible Preferred Stock, has a par value of $0.001, may be converted at the holder’s election into shares of common stock at the conversion rate of one share of common stock for one share of Preferred Stock. ~~As of September 30 ,2023 and December 31, 2022, there are no shares of Series AA and Super preferred stock outstanding.~~

~~Series~~As ~~A Convertible Preferred Stock, has a par value~~ of ~~$0.01,~~March may be converted at the holder’s election into shares of common stock at the conversion rate of ten shares of common stock for one share of Series A Preferred Stock. Each share is entitled to 10 votes31, ~~voting with the common stock as a single class~~2024, ~~has liquidation rights of $2.00 per share~~ and isDecember ~~not entitled to receive dividends. As of September 30~~31, 2023, ~~and~~there are ~~December~~0 ~~31,~~and ~~2022, there~~0 ~~are 33,815~~ shares of Series AAA and Super preferred stock outstanding, respectively.

Series B Convertible Preferred Stock, has a par value of $0.01, may be converted at the holder’s election into shares of common stock at the conversion rate of 40 shares of common stock for one share of Series B Preferred Stock. Each share is entitled to 4 votes, voting with the common stock as a single class, has liquidation rights of $0.01 per share and is not entitled to receive dividends. As of September 30, 2023 and December 31, 2022, there are 50 shares of Series B preferred stock outstanding.

Series C Convertible Preferred Stock, has a par value of $0.01, may be converted at the holder’s election into shares of common stock at the conversion rate of 400 shares of common stock for one share of Series C Preferred Stock. Each share is entitled to 400 votes, voting with the common stock as a single class, has liquidation rights of $0.01 per share and is entitled to receive four hundred times the dividends declared and paid with respect to each share of Common Stock. As of September 30, 2023 and December 31, 2022, there are 50,000 shares of Series C preferred stock outstanding.

Series DA Convertible Preferred Stock, has a par value of $0.~~0001~~01, may be converted at ~~a ratio of~~ the ~~Stated~~holder’s ~~Value~~election ~~plus~~into ~~dividends~~shares ~~accrued~~of ~~but~~common ~~unpaid~~stock ~~divided~~at by the ~~fixed~~ conversion ~~price~~ rate of ~~$0.0015,~~ten ~~which~~shares of ~~conversion~~common ~~price~~stock isfor ~~subject~~one toshare ~~adjustment.~~of Series DA isPreferred ~~non-voting,~~Stock. ~~has~~Each ~~liquidation~~share ~~rights~~is entitled to be10 ~~paid in cash~~votes, ~~before~~ ~~any~~voting ~~payment~~with tothe common orstock ~~junior~~as ~~stock~~a single class, ~~140%~~has ofliquidation ~~the~~rights ~~Stated~~of ~~Value (~~$2.00) per share ~~plus any dividends accrued but unpaid thereon~~ and is not entitled to 8%receive ~~cumulative~~ dividends. ~~As of September 30, 2023 and December 31, 2022, there are 1,250 shares of Series D preferred stock outstanding.~~

As of March 31, 2024, and December 31, 2023, there are 3,381,520 and 3,381,520 shares of Series A preferred stock outstanding, respectively.

Series B Convertible Preferred Stock, has a par value of $0.01, may be converted at the holder’s election into shares of common stock at the conversion rate of 4,000 shares of common stock for one share of Series B Preferred Stock. Each share is entitled to 4,000 votes, voting with the common stock as a single class, has liquidation rights of $0.01 per share and is not entitled to receive dividends.

As of March 31, 2024, and December 31, 2023, there are 5,000 and 5,000 shares of Series B preferred stock outstanding, respectively.

Series C Convertible Preferred Stock, has a par value of $0.01, may be converted at the holder’s election into shares of common stock at the conversion rate of 400 shares of common stock for one share of Series C Preferred Stock. Each share is entitled to 400 votes, voting with the common stock as a single class, has liquidation rights of $0.01 per share and is entitled to receive four hundred times the dividends declared and paid with respect to each share of Common Stock.

As of March 31, 2024, and December 31, 2023, there are 5,000,000 and 5,000,000 shares of Series C preferred stock outstanding, respectively.

Series D Convertible Preferred Stock, has a par value of $0.0001, may be converted at a ratio of the Stated Value plus dividends accrued but unpaid divided by the fixed conversion price of $0.0015, which conversion price is subject to adjustment. Series D is non-voting, has liquidation rights to be paid in cash, before any payment to common or junior stock, 140% of the Stated Value ($2.00) per share plus any dividends accrued but unpaid thereon and is entitled to 8% cumulative dividends.

As of March 31, 2024, and December 31, 2023, there are 125,000 and 125,000 shares of Series D preferred stock outstanding, respectively.

Series E Convertible Preferred Stock, has a par value of $0.001, and a stated value of $1.00 per share, subject to adjustment. The shares of Series E Convertible Preferred Stock can convert at a conversion price that is equal to the amount that is 61% of the lowest trading price of the Company’s common stock during the 20 trading days immediately preceding such conversion. The shares of Series E Convertible Preferred Stock are subject to redemption by the Company at its option from the date of issuance until the date that is 180 days therefrom, subject to premium that ranges from 120% to 145%, increasing by 5% during each 30-day period following issuance. Series E carries a 12% cumulative dividend, which will increase to 22% upon an event of default, is non-voting, and has liquidation rights to be paid in cash, before any payment to common or junior stock.

Series F Convertible Preferred Stock, has a par value of $0.001, may be converted at the holder’s election into shares of common stock at the current conversion rate of 93,~~762~~761,718 shares of common stock for one share of Series F Preferred Stock. Each share is entitled to 93,~~762~~761,718 votes, voting with the common stock as a single class, has no liquidation rights and is not entitled to receive dividends. ~~As of September 30, 2023 and December 31, 2022, there is 1 share of Series F preferred stock issued.~~

~~Series~~As ~~G Convertible Preferred Stock, has a par value~~ of ~~$0.001,~~March ~~may be converted at the holder’s election into shares of common stock for a period ending 18 months following issuance at the conversion rate that will result~~31, ~~in the aggregate~~2024, ~~in the holders of Series G Preferred Stock receiving that number of shares of Common Stock which equals Seventy Eight Percent (78%) of the total issued~~ and ~~outstanding~~December ~~shares of commons stock of the company on a fully diluted basis. The Series G Preferred Stock shall vote with the common stock as a single class~~31, ~~has liquidation rights of $0.001~~2023December ~~per share and is entitled to receive an annal dividend of 6% of the Stated Value (the “Divided Rate”)~~31, ~~which shall be cumulative~~2023, ~~payable~~ ~~solely~~there ~~upon redemption, liquidation, or conversion. There~~ are ~~10,000~~ 0 and 0 shares of Series G F preferred stock issued ~~as of September 30, 2023 and December 31, 2022~~.

Series HG Convertible Preferred Stock, has a par value of $0.001, may be converted at the ~~holders~~holder’s election into shares of common stock for a period ending 18 months following issuance at the conversion rate that ~~number~~will result, in the aggregate, in the holders of Series G Preferred Stock receiving that number of shares of ~~common~~Common ~~stock~~Stock which ~~shall~~equals ~~equal Twelve~~Seventy Eight Percent (1278%) of the total issued and outstanding shares of ~~Common~~commons ~~Stock~~stock of the company on a fully diluted basis,. The Series G Preferred Stock shall vote with ~~anti-dilution~~the common stock as a single class, has liquidation rights ~~until~~of $0.001 ~~twelve~~per share and is entitled to receive an annal dividend of 6% of the Stated Value (12the “Divided Rate”), ~~months~~which ~~from~~shall ~~the~~be ~~Issuance~~cumulative, payable ~~Date~~solely upon redemption, liquidation, or conversion.

~~During the~~There ~~year~~are ~~ended~~1,000,000 ~~December~~and 311, ~~2022~~000,000 asshares ~~consideration~~of ~~for~~Series G ~~the~~preferred ~~reverse~~stock ~~merger,~~issued ~~the~~as ~~Company~~of ~~issued~~March 1031,~~000~~ ~~shares~~2024 ofand ~~Series~~December G31, ~~Convertible~~2023, ~~Preferred stock~~respectively.

~~NOTE~~During 12the –year ~~RELATED~~ended ~~PARTY~~December ~~TRANSACTIONS~~31, 2022, as consideration for the reverse merger, the Company issued 1,000,000 shares of Series G Convertible Preferred stock.

~~For~~On ~~the~~November ~~years ended December 31~~18, ~~2022 and~~ 2021, ~~expenses~~ ofpursuant ~~$40,875 and~~to ~~$50~~the Founders Agreement,~~500 were~~ ~~incurred for recruitment services by an entity owned by~~ Michael ~~Neece~~Lakshin, ~~Chief~~President, ~~Product~~and ~~Officer. On~~Edward ~~December 16~~Aizman, ~~bowmo~~CEO, ~~Inc.~~were ~~(the~~issued ~~“Company”)~~500 ~~entered~~shares ~~into~~of anSuper ~~Asset~~Preferred ~~Purchase~~Stock ~~Agreement~~at ~~(the~~a ~~“APA”)~~fair ~~with~~value aof ~~related~~$50. ~~party,~~These ~~Interview~~preferred ~~Mastery Corporation (“Interview Mastery”)~~shares, aalong ~~Delaware~~with ~~corporation~~the 652,259 bySeries ~~and~~AA ~~through~~preferred ~~Michael R. Neece (“Neece”) and Caseridus~~stock, ~~Inc.~~were ~~See~~cancelled ~~Note~~on May 4., ~~Michael Neece~~2022, ~~the~~upon ~~seller~~completion of ~~Interview Mastery, is~~ the ~~chief~~Reverse Merger. ~~product~~See ~~officer~~Note ~~of the Company~~1.

Through December 31, 2022, the Company owed Eddie Aizman and Michael Lakshin compensation based on their employee agreements. The agreements provide for a salary of $200,000 and $180,000 per year, respectively. As of September 30, 2023 and December 31, 2022, $524,315 and $474,884 has been credited to accrued compensation and related payroll taxes.

On July 8, 2019, the Company executed an employment agreement with Conrad Huss. The agreement provides for a salary of $10,000 per month. As of September 30, 2023, $626,590 has been credited to accrued compensation and related payroll taxes.

The Company executed an employment agreement with Damian Hischier. The agreement provides for a salary of $10,000 per month. As of September 30, 2023, $86,120 has been credited to accrued compensation and related payroll taxes.

The Company executed an employment agreement with Keith Carlson. The agreement provides for a salary of $12,500 per month. As of September 30, 2023, $161,475 has been credited to accrued compensation and related payroll taxes.

NOTE 13 – COMMITMENTS AND CONTINGENCIES

Contingency arising from indebtedness owed to Oasis Capital, LLC

A contingency arises when there is a situation for which the outcome is uncertain, and which should be resolved in the future, Generally Accepted Accounting Principles require recognition of only those losses that are probable and for which a loss amount can be reasonably estimated.

The following details the nature of the contingency with Oasis Capital LLC (“Oasis”). In the normal course of its business, Oasis files notices to convert (“conversion notices”) a portion of its outstanding ownership of the Company’s indebtedness into shares of common stock. As a customary procedure for the annual audit for the period ended December 31, 2020, of Cruzani, Cruzani’s auditors confirmed its outstanding ~~balance~~ balance of the indebtedness and related accrued interest. During the year ended December 31, 2021, Oasis submitted conversions which stated ~~that~~ that the outstanding indebtedness was far greater than that which was on the Company’s books. The total amount of the increased ~~indebtedness~~ indebtedness was approximately $1.2 million. After investigation, the Company determined that the difference related to liquidated damages ~~that~~ that the Company does not believe that it owes.

Since the Company believes that the loss is not probable and no litigation has been pursued at this time, there has been no recognition of this liability on the books and records of the Company.

COVID-19 pandemic contingencies

The spread of the COVID-19 outbreak in the United States has resulted in economic uncertainties which may negatively impact the Company’s business operations. While the disruption is expected to be temporary, there is uncertainty surrounding the duration and extent of the impact. The impact of the coronavirus outbreak on the consolidated financial statements cannot be reasonably estimated at this time.

Adverse events such as health-related concerns about working in our offices, the inability to travel and other matters affecting the general work environment could harm our business and our business strategy. While we do not anticipate any material impact to our business operations as a result of the coronavirus, in the event of a major disruption caused by the outbreak of pandemic diseases such as coronavirus, we may lose the services of our employees or experience system interruptions, which could lead to diminishment of our business operations. Any of the foregoing could harm our business and delay the implementation of our business strategy and we cannot anticipate all the ways in which the current global health crisis and financial market conditions could adversely impact our business.

Management is actively monitoring the global situation on its financial condition, liquidity, operations, industry, and workforce.

Legal

During the normal course of business, the Company may be exposed to litigation. When the Company becomes aware of potential litigation, it evaluates the merits of the case in accordance with FASB ASC 450-20-50, Contingencies. The Company evaluates its exposure to the matter, possible legal or settlement strategies and the likelihood of an unfavorable outcome. If the Company determines that an unfavorable outcome is probable and can be reasonably estimated, it establishes the necessary accruals. A contingency arises when there is a situation for which the outcome is uncertain, and which should be resolved in the future, Generally Accepted Accounting Principles require recognition of only those losses that are probable and for which a loss amount can be reasonably estimated.

On February 13, 2017, Baum Glass & Jayne PLLC (“Plaintiff”) obtained a default judgment against the Company in the amount of $27,084. Plaintiff has not attempted enforced collection. The amount was included in accounts payable as of March 31, 2023.

NOTE 14 – INCOME TAX

There was no income tax expense reflected in the results of operations for the years ended December 31, 2023 and 2022 because the Company incurred a net loss for tax purposes.

As of December 31, 2023 and 2022, the Company had federal and state net operating loss carry forwards of $12,992,877 and $9,243,925, respectively which may be used to offset future taxable income. Approximately $1,696,000 will begin to expire in 2036 while $5,920,000 will not expire but will be limited in annual utilization of 80% of current year income.

The tax effects of temporary differences which give rise to deferred tax assets (liabilities) are summarized as follows:

	December 31, 2023			December 31, 2022
Deferred tax assets / (liabilities)
Net operating loss carry forward	$	3,361,000		$	2,923,000
Stock-based compensation		517,618			245,000
Accrued expenses		192,697			193,000
Net deferred tax assets		4,017,315			3,361,000
Valuation allowance		(4,017,315	)		(3,361,000	)
Net deferred tax assets, net of valuation allowance	$	-		$	-

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Deferred tax assets consist primarily of the tax effect of NOL carry-forwards. The Company has provided a full valuation allowance on the deferred tax assets because of the uncertainty regarding its realizability.

~~NOTE~~Reconciliation 14of –the ~~SUBSEQUENT~~statutory ~~EVENTS~~federal income tax to the Company’s effective income tax rate for the years ended December 31, 2023 and 2022:

The Company has completed an evaluation of all subsequent events through November 20, 2023, the date the financial statements were issued. Except as described below, the Company has concluded that no subsequent event has occurred that requires disclosure.

	December 31, 2023			December 31, 2022
Statutory federal income tax rate		21.0	%		21.00	%
State tax, net of federal benefit		15.29	%		15.29	%
Permanent differences		2.50	%		2.50	%
Valuation allowance		(38.79	)%		(38.79	)%
Effective rate		-	%		-	%

OnInternal ~~October~~Revenue ~~10,~~Code ~~2023,~~Section 382 limits the ~~Company~~ability to ~~effected~~utilize net operating losses if a ~~reverse split~~50% ofchange ~~its~~in ~~authorized~~ownership ~~and~~occurs ~~issued~~over ~~and~~a ~~outstanding~~three-year ~~common~~period. ~~stock~~Such limitation of the net operating losses may have occurred, ~~par~~but ~~value~~we ~~$0.00001~~have not analyzed it at athis ~~ratio~~time ofas ~~1:100~~the deferred tax asset is fully reserved.

~~Through~~On ~~November~~March 2027, ~~2023~~2020, the ~~Company~~US ~~issued~~government ~~two~~signed the ~~convertible~~CARES ~~notes.~~Act ~~The~~into ~~principal~~law, ~~amounts~~a of$2 ~~these~~trillion ~~notes~~relief ~~are~~package ~~$10~~to provide support to individuals,~~000~~ ~~each~~businesses, ~~for~~and agovernment ~~total~~organizations ~~amount~~during ofthe COVID-19 ~~$20,000~~pandemic. ~~They~~During ~~bear~~2020, ~~interest~~$91,035 atin ~~12%~~PPP ~~and are~~relief ~~due~~was inreceived ~~full~~under onthe ~~August~~CARES ~~31,~~Act ~~2024~~ and ~~September~~was ~~30,~~forgiven ~~2024,~~free ~~respectively~~of taxation in 2021.

OnThe ~~November~~Company’s 14policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the statement of operations. As of December 31, 2023, and 2022 the Company ~~issued~~had ~~two~~no ~~convertible notes~~unrecognized ~~payable~~tax benefits. There were no changes in the ~~principal~~Company’s ~~amount~~unrecognized oftax ~~$14,500~~benefits during ~~and~~the ~~$22~~years ended December 31,~~500,~~ ~~respectively~~2023 and 2022. The ~~notes~~Company ~~accrue~~did not recognize any interest ator ~~12%~~penalties ~~per~~during ~~annum~~fiscal 2023 or 2022 related to unrecognized tax benefits.

~~From~~For ~~October~~the 18years ~~through~~ended ~~November~~December 1531, 2023, ~~the Company~~and ~~issued 7~~2022,~~401,999 shares of~~ the ~~Company’s~~net ~~common~~increase ~~stock~~in ~~upon~~valuation ~~conversion~~allowance ofwas ~~principal~~approximately $710,315 and ~~interest~~$1,777,000, ~~on its notes payable~~respectively.

Tax years 2018-2021 remain open to examination for federal income tax purposes and by other major taxing jurisdictions to which the Company is subject.

NOTE 15 – SUBSEQUENT EVENTS

Through March 31, 2024, the Company issued three convertible notes. The total principal amount of these notes is $30,000. They bear interest at 12% and are payable at October 31, 2024, November 30, 2024 and December 31, 2024, respectively. The Company granted 150,000 warrants to purchase 150,000 shares of the Company’s common stock with these convertible notes. These warrants have an exercise price of $0.0001 and a term of five years.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The statements contained in the following MD&A and elsewhere throughout this Quarterly Report on Form 10-Q, including any documents incorporated by reference, that are not historical facts, including statements about our beliefs and expectations, are “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking ~~Looking~~statements ~~Statements~~include statements preceded by, followed by or that include the words “may,” “could,” “would,” “should,” “believe,” “expect,” “anticipate,” “plan,” “estimate,” “target,” “project,” “intend” and similar words or expressions. In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances are forward-looking statements.

~~This~~These ~~Quarterly Report on Form 10-Q contains~~ forward-looking statements., ~~For~~which ~~this~~reflect ~~purpose,~~our ~~any~~management’s ~~statements~~beliefs, ~~contained~~objectives, inand ~~this~~expectations ~~Report~~as ~~that~~of ~~are~~the ~~not~~date ~~statements~~hereof, ofare ~~historical~~based ~~fact~~on ~~may~~the bebest ~~deemed~~judgement of toour bemanagement. All forward-looking statements. ~~Forward-looking~~speak ~~information~~only ~~includes~~as ~~statements~~of ~~relating~~the todate ~~future~~on ~~actions,~~which ~~prospective~~they ~~products,~~are ~~future~~made. ~~performance~~Such orforward-looking ~~results~~statements are ofsubject ~~current~~to orcertain ~~anticipated products~~risks, ~~sales~~uncertainties and ~~marketing~~assumptions ~~efforts,~~relating ~~costs~~to ~~and~~factors ~~expenses,~~that ~~interest~~could ~~rates,~~cause ~~outcome~~actual ofresults ~~contingencies,~~to ~~financial~~differ materially from ~~condition,~~those ~~results~~anticipated ofin ~~operations~~such statements, ~~liquidity~~including, ~~business~~without ~~strategies~~limitation, ~~cost~~the ~~savings~~following: economic, ~~objectives~~social ofand ~~management~~political conditions, ~~and~~global economic ~~other~~downturns ~~matters.~~resulting ~~You~~from ~~can~~extraordinary ~~identify forward-looking~~events ~~statements~~and byother ~~those~~securities ~~that~~industry ~~are~~risks; ~~not~~interest ~~historical~~rate inrisks; ~~nature,~~liquidity ~~particularly~~risks; ~~those~~credit risk ~~that~~with ~~use~~clients ~~terminology~~and ~~such~~counterparties; asrisk ~~“may,” “will,”~~of ~~“should,”~~liability ~~“expects,”~~for ~~“anticipates,”~~errors ~~“contemplates,”~~in ~~“estimates,” “believes,”~~clearing ~~“plans,”~~functions; ~~“projected,”~~systemic ~~“predicts,”~~risk; ~~“potential~~systems failures,” ordelays ~~“continue”~~ and capacity ~~similar~~constraints; ~~expressions~~network orsecurity ~~the~~risks; ~~negative~~competition; ofreliance ~~these~~on ~~similar~~external ~~terms.~~service ~~The~~providers; ~~Private~~new ~~Securities~~laws ~~Litigation~~and ~~Reform~~regulations ~~Act~~affecting our ofbusiness; ~~1995~~net ~~provides~~capital arequirements; ~~“safe harbor”~~extensive ~~for~~regulation, ~~forward-looking~~regulatory ~~information~~uncertainties toand ~~encourage~~legal ~~companies~~matters; failure to ~~provide~~maintain ~~prospective~~relationships with ~~information~~employees, ~~about~~customers, ~~themselves~~business ~~without~~partners ~~fear of~~or ~~litigation~~governmental soentities; ~~long~~the asinability ~~that~~to ~~information~~achieve issynergies ~~identified~~or asto ~~forward-looking~~implement integration plans and isother ~~accompanied~~consequences byassociated ~~meaningful~~with ~~cautionary~~risks ~~statements~~and ~~identifying important~~uncertainties ~~factors~~detailed ~~that~~in ~~could~~our ~~cause~~filings ~~actual~~with ~~results~~the toSEC, ~~differ~~including ~~materially~~our ~~from~~most ~~those~~recent ~~projected~~filings on inForms ~~the~~10-K ~~information~~and 10-Q.

~~These~~We ~~forward-looking~~caution ~~statements~~that ~~are~~the ~~not guarantees~~foregoing list of ~~future~~factors ~~performance~~is ~~and~~not ~~involve risks~~exclusive, ~~uncertainties~~ and ~~assumptions~~new ~~that we cannot predict. In evaluating these forward-looking statements, you should consider various~~ factors, ~~including~~may ~~the following: (a) those risks and uncertainties related to general economic conditions~~emerge, ~~(b)~~ ~~whether we are able to manage our planned growth efficiently and operate profitable operations, (c) whether we are able to generate sufficient revenues~~ or ~~obtain~~changes ~~financing~~ to ~~sustain~~the ~~and~~foregoing ~~grow~~factors ~~our~~may ~~operations~~occur, ~~(d)~~that ~~whether~~could weimpact ~~are able to successfully fulfill~~ our ~~primary requirements for cash, which are explained below under “Liquidity and Capital Resources”~~business. We ~~assume~~undertake no obligation to publicly update ~~forward-looking~~ ~~statements,~~or ~~except~~revise asthese ~~otherwise required under the applicable federal securities laws. Unless stated otherwise~~statements, ~~terms such~~whether as ~~the~~a ~~“Company,”~~result ~~“bowmo,”~~of ~~“we,”~~new ~~“us~~information,” ~~“our,”~~future ~~and~~events ~~similar~~or ~~terms shall~~otherwise, ~~refer~~except to ~~bowmo,~~the ~~Inc.,~~extent arequired ~~Wyoming~~by ~~corporation,~~the ~~and~~federal ~~its~~securities ~~subsidiaries~~laws.

~~Acquisitions~~Certain information contained in this discussion and elsewhere in this report may include “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and is subject to the safe harbor created by that act. The safe harbor created by the Private Securities Litigation Reform Act will not apply to certain “forward looking statements” because we issued “penny stock” (as defined in Section 3(a)(51) of the Securities Exchange Act of 1934 and Rule 3(a)(51-1) under the Exchange Act) during the three year period preceding the date(s) on which those forward looking statements were first made, except to the extent otherwise specifically provided by rule, regulation or order of the Securities and Exchange Commission. We caution readers that certain important factors may affect our actual results and could cause such results to differ materially from any forward-looking statements which may be deemed to have been made in this Report or which are otherwise made by or on our behalf. For this purpose, any statements contained in this report that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as “may,” “will,” “expect,” “believe,” “explore,” “consider,” “anticipate,” “intend,” “could,” “estimate,” “plan,” or “propose” or the negative variations of those words or comparable terminology are intended to identify forward-looking statements. Factors that may affect our results include, but are not limited to, the risks and uncertainties associated with:

~~Interview~~● ~~mastery~~Our ability to raise capital necessary to sustain our anticipated operations and implement our business plan, ● Our ability to implement our business plan, ● Our ability to generate sufficient cash to survive, ● The degree and nature of our competition, ● The lack of diversification of our business plan, ● The general volatility of the capital markets and the establishment of a market for our shares, and ● Disruption in the economic and financial conditions primarily from the impact of past terrorist attacks in the United States, threats of future attacks, police and military activities overseas and other disruptive worldwide political and economic events and environmental weather conditions.

OnWe ~~December~~are 16also ~~2022,~~subject ~~bowmo,~~to other ~~Inc.~~risks ~~(the~~detailed ~~“Company”) entered~~from ~~into~~time anto ~~Asset~~time ~~Purchase~~in ~~Agreement~~our ~~(the~~other ~~“APA”)~~filings with ~~Interview~~SEC ~~Mastery Corporation (“Interview Mastery”), a Delaware corporation, by~~ and ~~through~~elsewhere ~~Michael~~in R.this ~~Neece~~Annual ~~(“Neece”) and Caseridus, Inc~~Report. ~~Under~~Any ~~the~~one ~~terms~~or ofmore ~~the APA, the Company will pay the purchase price through the issuance~~ of ~~2,000,000,000~~these ~~shares of the Company’s common stock in two tranches: (i) 1~~uncertainties,~~000,000,000~~ ~~shares~~risks ofand ~~Company~~other ~~common~~influences ~~stock~~could tomaterially ~~the~~affect ~~stockholders~~our ofresults ~~Interview Mastery that vest immediately for all~~ of ~~the~~operations ~~business assets of Interview Mastery, valued at $200,000 based on the acquisition date share price of $0.0002;~~ and ~~(ii)~~whether 1,000,000,000 shares of Company common stock issued in consideration of Neece’s employment with the Company which shall vest over a four (4) year period during which 250,000,000 shares will vest on the firstforward-~~year~~looking ~~anniversary~~statements ofmade ~~Neece’s employment, followed~~ by ~~vesting~~us ~~in increments of 62,500,000 shares per~~ultimately ~~quarter~~prove ~~(3-month~~to ~~period) thereafter until the full amount is vested and all of which shall~~ be ~~contingent upon Neece’s continual employment with the Company~~accurate. AsOur ofactual ~~December 31~~results, ~~2022,~~performance ~~the~~and ~~1,000,000,000~~achievements ~~shares~~could ofdiffer ~~common~~materially ~~stock~~from ~~for~~those ~~the~~expressed ~~acquisition~~or ofimplied ~~Interview~~in ~~Mastery~~these ~~have~~forward-looking ~~not~~statements. ~~been~~We ~~issued,~~undertake ~~and~~no asobligation ~~such,~~to ~~has~~publicly ~~been~~update ~~recorded~~or asrevise aany ~~liability~~forward-looking ~~in accrued expenses on the consolidated balance sheets. In connection with the APA~~statements, ~~the~~whether ~~Company~~from ~~shall create a~~ new ~~board seat and offer such seat to Neece who will be formally invited to join the Company’s~~information, ~~Board~~future ofevents ~~Directors~~or otherwise.

The acquisition was accounted for as a business combination in accordance with the acquisition method under the guidance in ASC 805-10 and 805-20. This business combination was accounted for as a related party acquisition, as Neece is the chief product officer of the Company Accordingly, the total purchase consideration was allocated to net acquired based on their respective historical costs. The assets acquired, and liabilities assumed, if any, in a business purchase combination be recognized at their historical costs as of the acquisition date.

The final allocation of the purchase price in connection with the Interview Mastery acquisition was calculated as follows:

Description	Fair Value
Cash	$	1,633
Prepaid expenses		997
Loss on acquisition – related party		197,370
	$	200,000

Recent Event

On March 22, 2024, we entered into a Plan and Agreement of Merger (the “Merger Agreement”) with OWNverse, LLC, a Delaware limited liability company (“OWNverse”), pursuant to which OWNverse would become a wholly-owned subsidiary of our company. Pursuant to the Merger Agreement, our company would deliver an aggregate of 2,000 shares of to-be-designated Series I Preferred Stock of the Company, an aggregate of $2,000,000 in principal amount promissory notes that are to be due and payable two years from their issuance dates and promissory notes with an aggregate of up to $270,000 that are to be due and payable six months from their issuance dates. The consummation of the Merger Agreement has not been completed, due to our company’s lack of capital. There is no assurance that we will be able to obtain sufficient capital to do so. However, the owners of OWNverse remain, as of the date of this Quarterly Report, committed to completing the Merger.

2022 Acquisition – Interview Mastery

Effective December 16, 2022, pursuant to an Asset Purchase Agreement (the “APA”) with Interview Mastery (“Interview Mastery”), by and through Michael R. Neece (“Neece”) and Caseridus, Inc. Under the terms of the APA, the Company is to pay the purchase price through the issuance of 22,000,000 shares of the Company’s common stock in two tranches: (i) 11,000,000 shares of Company common stock to the stockholders of Interview Mastery that vest immediately for all of the business assets of Interview Mastery, valued at $200,000 based on the acquisition date share price; and (ii) 11,000,000 shares of Company common stock issued in consideration of Neece’s employment with the Company which shall vest over a four (4) year period during which 25% of the shares will vest on the first-year anniversary of Neece’s employment, followed by vesting in increments of 6.25% of the shares per quarter (3-month period) thereafter until the full amount is vested and all of which shall be contingent upon Neece’s continual employment with the Company. As of the date of this Annual Report, none of the shares issuable in connection with the APA has been issued, and as such, has been recorded as a liability in accrued expenses on the consolidated balance sheets. In connection with the APA, the Company is to create a new board seat and offer such seat to Neece who will be formally invited to join the Company’s Board of Directors. As of the date of this Annual Report, none of these actions has been taken by the Company.

This acquisition was accounted for as a business combination in accordance with the acquisition method under the guidance in ASC 805-10 and 805-20. This business combination was accounted for as a related party acquisition, as Neece is the chief product officer of the Company Accordingly, the total purchase consideration was allocated to net acquired based on their respective historical costs. The assets acquired, and liabilities assumed, if any, in a business purchase combination be recognized at their historical costs as of the acquisition date.

The final allocation of the purchase price in connection with the Interview Mastery acquisition was calculated as follows:

Description	Fair Value		Weighted Average Useful Life (Years)
Cash	$	1,633
Prepaid expenses		997
Loss on acquisition – related party		197,370

No acquisition costs were incurred. The approximate revenue and net loss for the acquired business as a standalone entity per ASC 805 from January 1, 2021, to December 31, 2021, was $14,692 and $21,862, respectively, and, from January 1, 2022, to December 16, 2022, $13,059 and $15,279, respectively.

Results of Operations

The following discussion and analysis of the results of operations and financial condition for the three months ~~and nine months~~ ended ~~September~~March 3031, ~~2023~~2024 and ~~2022~~2023, should be read in conjunction with our consolidated financial statements and the notes to those consolidated financial statements that are included elsewhere in this ~~Annual~~ Quarterly Report. Our discussion includes forward-looking statements based upon current expectations that involve risks and uncertainties, ~~such~~ such as our plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those ~~anticipated~~ anticipated in these forward-looking statements as a result of a number of factors. See “Forward-Looking Statements.”

Three Months Ended ~~September~~March 3031, ~~2023~~2024, Compared to the Three Months Ended ~~September~~March 3031, ~~2022~~2023.

	For the three months ended
	September 30, 2023			September 30, 2022
				(as Restated)
Revenue	$	62,000		$	-
Cost of revenue		-			-
Gross profit		62,000			-
Operating expenses:
Compensation expense		209,302			98,375
Consulting fees		30,000			75,000
Professional fees		3,415			117,119
General and administrative		67,163			68,820
Total operating expenses		309,880			359,314
Loss from operations		(247,880	)		(359,314	)
Other income (expenses):
Interest expense		(169,369	)		(200,269	)
Gain on new methodology for accounting for debt conversion features		-			-
Change in fair value of derivative liability		(580,189	)		-
Total other income (expenses)		(749,558	)		(200,269	)
Income (loss) before income taxes		(997,438	)		(559,583	)
Provision for income taxes		-			-
Net Loss		(997,438	)		(559,583	)

Revenue. We derived no revenues from operations for the three months ended March 31, 2024, compared to revenues for the three months ended March 31, 2023, of $4,476. Our lack of revenues during current period is due to our lack of operating capital. We are unable to predict if and when we will obtain the capital needed to begin to generate revenues again.

Revenue

Revenues for the three months ended September 30, 2023 totaled $62,000, an increase of $62,000 or 100% compared to $0 of revenues for the three months ended September 30, 2022. This was primarily due to decreased operations for the three months ended September 30, 2022.

Cost of Revenue

Cost of revenues for the three months ended September 30, 2023 and 2022 totaled $0. This was primarily a result of decreased operations for both periods.

Compensation Expense

Compensation expense for the three months ended September 30, 2023 and September 30, 2022 was $209,302 and $98,375, respectively, and consists entirely of compensation paid to officers. The increase is attributable to accrued compensation for two additional officers during the three months ended September 30, 2023.

~~Consulting~~Cost ~~Expense~~of Revenue. Cost of revenues for the three months ended March 31, 2024 and 2023, were $0.

~~Consulting~~Compensation ~~expense~~Expense. Compensation expense for the three months ended ~~September~~ ~~30,~~March ~~2023~~31, ~~and September 30~~2024, ~~2022~~ was $30125,000, ~~and~~compared ~~$75~~to the three months ended March 31,~~000~~ 2023, ~~respectively.~~when ~~The~~we ~~decrease~~reported ~~can~~compensation expense beof ~~attributed~~$121,314. toIn anboth ~~effort~~periods, tocompensation ~~cut~~expense ~~costs during~~consisted ~~the~~entirely ~~three~~of ~~months~~compensation ~~ended~~paid ~~September~~and ~~30,~~accrued ~~2023~~to officers.

~~General~~Consulting ~~and~~Expense. ~~administrative~~Consulting expense for the three months ended March 31, 2024, was $0, compared to the three months ended March 31, 2023, when consulting expenses was $30,000.

General and Administrative Expenses. General and administrative expenses for the three months ended ~~September~~March 3031, ~~2023~~2024, ~~were~~was $6731,~~163~~249, compared to $6876,~~820~~581 for the three months ended ~~September 30~~March 31, ~~2022~~2023. ~~General~~The ~~and~~decrease ~~administrative expenses~~in ~~remained~~the ~~relatively~~current inperiod ~~line~~is ~~during~~attributable ~~the~~to ~~corresponding~~our ~~periods~~lack of operating capital.

Professional fees. Professional fees for the three months ended March 31, 2024, were $39,500, compared to $160,054 for the three months ended March 31, 2023. The decrease in professional fees is primarily due to our lower level of operations required by our lack of operating capital.

~~Professional~~Other ~~fees~~Income ~~for~~(Expense). For the three months ended ~~September 30~~March 31, ~~2023~~2024, ~~were~~total ~~$3,415~~other ~~compared~~expense towas $~~117~~356,~~119~~126, ~~for~~comprised ~~the~~exclusively of change in fair value of derivative liability. For the three months ended ~~September~~March 3031, ~~2022.~~2023, ~~The~~total ~~decrease~~other inincome ~~expenses~~of $1,001,115 was ~~due~~primarily attributable to ~~lower~~the ~~legal expenses~~recognition ~~during~~and change in the ~~three~~value of ~~months~~derivative ~~ended~~liabilities ~~September~~of 30$1,270,615 ~~2023~~off set by interest expense of $(269,500).

~~Other~~Net Income (~~Expense~~Loss). The Company reported a net loss of $551,875 for the three months ended March 31, 2024, compared to net income of $617,642 for the three months ended March 31, 2023.

~~Total~~Liquidity ~~other~~and ~~income~~Capital (expense) of $749,558 for the three months ended September 30, 2023 was primarily attributable to the change in the value of derivative liabilities of $580,189 as well as interest expense of $169,369. Total other expense of $200,269 for the three months ended September 30, 2022, was comprised of interest expense of $200,269.Resources

~~Net~~For ~~Income~~the ~~(Loss)~~three months ended March 31, 2024, we used $84,299 of cash in operating activities, compared to the three months ended March 31, 2023, when we used $79,487 of cash in operating activities.

~~The~~For ~~Company had a net loss of $997,438 for~~ the three months ended ~~September~~March 3031, 2024 and 2023, asinvesting ~~compared~~activities todid anot ~~net~~use ~~loss~~or ofprovide ~~$559,583 for the three months ended September 30, 2022~~cash.

~~Nine~~For ~~Months~~the ~~Ended~~three ~~September~~months 30ended March 31, ~~2023~~2024, ~~Compared~~financing activities provide $80,000 of cash, compared to the ~~Nine~~for ~~Months~~the ~~Ended~~three ~~September~~months 30ended March 31, ~~2022~~2023, when financing activities neither used nor provided cash.

	For the nine months ended
	September 30, 2023			September 30, 2022
				(as Restated)
Revenue	$	66,476		$	149,848
Cost of revenue		-			48,470
Gross profit		66,476			101,378
Operating expenses:
Compensation expense		431,421			301,660
Consulting fees		90,000			1,486,514
Professional fees		166,884			247,837
General and administrative		174,584			123,735
Total operating expenses		862,889			2,159,746
Loss from operations		(796,413	)		(2,058,368	)
Other income (expenses):
Interest expense		(666,774	)		(243,429	)
Gain on new methodology for accounting for debt conversion features		-			27,856
Initial recognition of derivative liability		(32,429	)		-
Change in fair value of derivative liability		(149,909	)		(1,545	)
Total other income (expenses)		(849,112	)		(217,118	)
Income (loss) before income taxes		(1,645,525	)		(2,275,486	)
Provision for income taxes		-			-
Net Loss		(1,646,,525	)		(2,275,486	)

The Company currently owes approximately $500,000 on non-convertible loans payable, all of which are in default, and approximately $450,000 for outstanding convertible notes, net of discounts, all of which are in default.

In addition, entities negatively impacted by the COVID-19 pandemic were eligible to apply for loans sponsored by the United States Small Business Administration (SBA) Economic Injury Disaster Loan (“EIDL Loan”) program. On July 15, 2020, the Company received cash proceeds of $40,400 under this program. In addition, in July 2020, the Company received $6,000 from the SBA as a COVID-19 Economic Injury Disaster Loan Advance (the “EIDL Advance”). The proceeds can be used to fund payroll, healthcare benefits, rent and other qualifying expenses, and the loan is not subject to a loan forgiveness provision. The standard EIDL Loan repayment terms include interest accruing at 3.75% per annum effective July 15, 2020; the payment schedule contains a one-year deferral period on initial principal and interest payments; the loan term is thirty years; and there is no prepayment penalty or fees. The Company pledged all assets of the Company as collateral for the loan. As of December 31, 2021, the amounts outstanding totaled $40,400, and was classified as part of notes payable on the consolidated balance sheet. Additionally, the Company entered into a security agreement with the SBA in which this promissory note is collateralized by all tangible and intangible assets of the Company. In addition, the Company’s CEO, Edward Aizman, provided his personal guaranty of the EIDL Loan and pledged certain of his personal assets in conjunction with his guaranty. On January 6, 2021, the SBA announced a one-year extension of the deferral period for loans that commenced in 2020 delaying payments of principal and interest to July 2022. Pursuant to an SBA Procedural Notice in December 2020, the EIDL Advance was forgiven. The Company has recognized the entire EIDL Advance amount of $6,000 as grant income, which is included in other income (expense) in the consolidated statement of operations for the year ended December 31, 2021.

In February 2022, the Company agreed to the first and second modifications of the EIDL Loan. The EIDL was modified to include additional borrowings of $269,200, which were received in full in February 2022. Periodic monthly payments have increased to $1,556 in the first modification and reduced to $1,506 in the second modification. Additionally, the Company entered into an amended security agreement with the SBA in which this promissory note, and the modifications, is collateralized by all tangible and intangible assets of the Company. The balance of the EIDL loan balance at December 31, 2023 is $309,500, respectively. The Company is in default under the EIDL Loan and the EIDL Loan has been referred by the SBA to the U.S. Treasury Offset Program. The Company is currently in the process of addressing the charged-off status of the EIDL Loan with the SBA and simultaneously submitting an application to the SBA’s Hardship Accommodation Program (HAP), whereby the Company hopes to receive some relief while arranging for, and keeping current, reduced payments thereon. There is no assurance that the Company will be able to secure any such relief.

Revenue

Revenues for the nine months ended September 30, 2023 totaled $66,476, a decrease of $83,372 or 56% compared to $149,848 of revenues for the nine months ended September 30, 2022. This was primarily due to decreased operations for the nine months ended September 30, 2023.

Cost of Revenue

Cost of revenues for the nine months ended September 30, 2023 totaled $0, a decrease of $48,470 or 100% compared to $48,470 cost of revenues for the nine months ended September 30, 2022. This was primarily a result of decreased operations for the nine months ended September 30, 2023.

Compensation Expense

Compensation expense for the nine months ended September 30, 2023 and September 30, 2022 was $431,421 and $301,660, respectively, and consists entirely of compensation paid to officers.

Consulting Expense

Consulting expense for the nine months ended September 30, 2023 and September 30, 2022 was $90,000 and $1,486,514, respectively. The decrease can be attributed to expense of $1,364,847 related to a consulting agreement signed during May 2022 that included the issuance of shares of Series H preferred stock in exchange for services.

General and administrative expenses

General and administrative expenses for the nine months ended September 30, 2023 were $174,584 compared to $123,735 for the nine months ended September 30, 2022. The increase was primarily due to the addition of stock based compensation issued to an officer of the Company.

Professional fees

Professional fees for the nine months ended September 30, 2023 were $166,884 compared to $247,837 for the nine months ended September 30, 2022. The decrease in expenses was due to a decrease legal expenses.

Other Income (Expense)

Total other expense of $849,112 for the nine months ended September 30, 2023 was primarily attributable to the interest expense of $666,774 as well as the initial recognition of derivative liability of $32,429; offset by a gain on the change in the fair value of the derivative liability of $149,909. Total other expense of $217,118 for the nine months ended September 30, 2022, was comprised of interest expense of $243,429 and a loss on the change in the fair value of derivatives of $1,545; offset by a gain on new methodology for accounting for debt conversion features of $27,856.

Net Income (Loss)

The Company had net loss of $1,645,525 for the nine months ended September 30, 2023, as compared to a net loss of $2,275,486 for the nine months ended September 30, 2022.

Quarterly Developments

None.

Significant Developments

On May 4, 2022, Cruzani, Inc., acquired Bowmo Inc. for the issuance of the Company’s Series G Preferred Stock holding the voting rights to 78% of the total voting equity securities. bowmo Inc. (“bowmo”) is an Artificial intelligence Human resource technology company delivering software and services that transform the hiring process. We provide our services to a broad range of clients in major cities around the world. bowmo and its predecessors have been a leadership advisor for more than 60 years. bowmo was formed as a Delaware corporation in 2015 by Robert Boyer and J. Strother Moore who in 1977 created the Boyer-Moore string-search algorithm, which serves as a predecessor algorithm for all search modalities such as Google.

Going Concern

The accompanying unaudited interim consolidated condensed financial statements have been prepared in conformity with generally accepted accounting principles which contemplate continuation of the Company on a going-concern basis. The going concern basis assumes that assets are realized, and liabilities are extinguished in the ordinary course of business at amounts disclosed in the consolidated financial statements. The Company has incurred recurring losses from operations and has an accumulated deficit of $12(13,544,752).25 ~~million.~~ The Company’s ability to continue as a going concern depends upon its ability to obtain adequate funding to support its operations through continuing investments of debt and/or equity by qualified investors/creditors, ~~internally~~ internally generated working capital and monetization of intellectual property assets. These factors raise substantial doubt about the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Management is currently pursuing a business strategy which includes raising the necessary funds to finance the Company’s development and marketing efforts.

Critical Accounting Estimates and Policies

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Note 1 to the Financial Statements describes the significant accounting policies and methods used in the preparation of the Financial Statements. Estimates are used for, but not limited to, contingencies and taxes. Actual results could differ materially from those estimates. The following critical accounting policies are impacted significantly by judgments, assumptions, and estimates used in the preparation of the Financial Statements.

We are subject to various loss contingencies arising in the ordinary course of business. We consider the likelihood of loss or impairment of an asset or the incurrence of a liability, as well as our ability to reasonably estimate the amount of loss in determining loss contingencies. An estimated loss contingency is accrued when management concludes that it is probable that an asset has been impaired or a liability has been incurred and the amount of the loss can be reasonably estimated. We regularly evaluate current information available to us to determine whether such accruals should be adjusted.

We recognize deferred tax assets (future tax benefits) and liabilities for the expected future tax consequences of temporary differences between the book carrying amounts and the tax basis of assets and liabilities. The deferred tax assets and liabilities represent the expected future tax return consequences of those differences, which are expected to be either deductible or taxable when the assets and liabilities are recovered or settled. Future tax benefits have been fully offset by a 100% valuation allowance as management is unable to determine that it is more likely than not that this deferred tax asset will be realized.

Recent Accounting Pronouncements

The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

Off Balance Sheet Arrangements

We have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources and would be considered material to investors.

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

Not applicable to smaller reporting companies.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are designed to be effective in providing reasonable assurance that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission (the “SEC”), and that such information is accumulated and communicated to our management to allow timely decisions regarding required disclosure. Our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, they concluded that our disclosure controls and procedures were not effective for the quarterly period ended ~~September~~March 3031, ~~2023~~2024.

The following aspects of the Company were noted as potential material weaknesses:

1. We do not have written documentation of our internal control policies and procedures. Written documentation of key internal controls over financial reporting is a requirement of Section 404 of the Sarbanes-Oxley Act which is applicable to us for the period ended ~~September~~March 3031, ~~2023~~2022. Management evaluated the impact of our failure to have written documentation of our internal controls and procedures on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness.

We do not have sufficient resources in our accounting function, which restricts the Company’s ability to gather, analyze and properly review information related to financial reporting in a timely manner. As a result, as of the date of filing, we have not completed our ASC 606 implementation process and, thus, cannot disclose the quantitative impact of adoption on our financial statements. In addition, due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. However, to the extent possible, the initiation of transactions, the custody of assets and the recording of transactions should be performed by separate individuals. Management evaluated the impact of our failure to have segregation of duties on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness.

We have inadequate controls to ensure that information necessary to properly record transactions is adequately communicated on a timely basis from non-financial personnel to those responsible for financial reporting. Management evaluated the impact of the lack of timely communication between non–financial personnel and financial personnel on our assessment of our reporting controls and procedures and has concluded that the control deficiency represented a material weakness.

Certain control procedures were unable to be verified due to performance not being sufficiently documented. As an example, some procedures requiring review of certain reports could not be verified due to there being no written documentation of such review. Management evaluated the impact of its failure to maintain proper documentation of the review process on its assessment of its reporting controls and procedures and has concluded deficiencies represented a material weakness.

In designing and evaluating disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute assurance of achieving the desired objectives. Also, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs.

Changes in Internal Controls

Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that no change occurred in the Company’s internal controls over financial reporting during the quarter ended ~~September~~March 3031, ~~2023~~2024, that has materially affected, or is reasonably likely to materially affect, the Company’s internal controls over financial reporting.

2726

PART II – OTHER INFORMATION

Item. 1. Legal Proceedings.

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.

OnAs ~~February~~of ~~13,~~the ~~2017,~~date ~~Baum~~of ~~Glass~~this &filing, ~~Jayne~~there ~~PLLC~~are no material ~~(“Plaintiff”)~~pending ~~obtained~~legal aor ~~default~~governmental ~~judgment~~proceedings ~~against~~relating ~~the~~to our Company inor ~~the~~properties ~~amount~~to which we are a party, and, to our knowledge, there are no material proceedings to which any of ~~$27~~our directors,~~083.74.~~ ~~Plaintiff~~executive ~~has~~officers, ~~not~~or ~~attempted~~affiliates ~~enforced~~are a party adverse to us or which have a ~~collection~~material interest adverse to us.

Item 1A. Risk Factors.

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and, as such, are not required to provide the information under this Item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

~~September~~We ~~30,~~issued ~~2023~~no ~~See~~securities ~~Note Eight above for all unregistered sales of equity~~ during the ~~Nine~~three months ended ~~September~~March 3031, ~~2022~~2024, not previously reported.

Item 3. Defaults Upon Senior Securities.

None

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

Item 6. Exhibits

Exhibit		Description
31		Section 302 Certification of Principal Executive Officer and Financial Officer*
31.1		Section 302 Certification of Principal Executive Officer and Financial Officer*
32		Section 906 Certification of Principal Executive Officer and Financial Officer*
32.1		Section 906 Certification of Principal Executive Officer and Financial Officer*
101.INS		Inline XBRL Instance Document.
101.SCH		Inline XBRL Taxonomy Extension Schema Document.
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

*	filed herewith

2827

SIGNATURES

In accordance with the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	BOWMO, INC.
Date: November 21, 2023	By:	/s/ Michael Lakshin
Date: October 29, 2024	By:	/s/ Michael Lakshin
	Name:	Michael Lakshin
	Title:	President and Chairman of the Board
		(Principal Executive Officer)
		(Principal Financial and Accounting Officer)

2928

NONE 18514334 31260512 33300997 8488816 0.00 0.00 0.00 0.00 50000 false --12-31 Q3 0001381871 0001381871 2023-01-01 2023-09-30 0001381871 2023-11-21 0001381871 2023-09-30 0001381871 2022-12-31 0001381871 us-gaap:SeriesAPreferredStockMember 2023-09-30 0001381871 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001381871 us-gaap:SeriesBPreferredStockMember 2023-09-30 0001381871 us-gaap:SeriesBPreferredStockMember 2022-12-31 0001381871 us-gaap:SeriesCPreferredStockMember 2023-09-30 0001381871 us-gaap:SeriesCPreferredStockMember 2022-12-31 0001381871 us-gaap:SeriesDPreferredStockMember 2023-09-30 0001381871 us-gaap:SeriesDPreferredStockMember 2022-12-31 0001381871 us-gaap:SeriesEPreferredStockMember 2023-09-30 0001381871 us-gaap:SeriesEPreferredStockMember 2022-12-31 0001381871 us-gaap:SeriesGPreferredStockMember 2023-09-30 0001381871 us-gaap:SeriesGPreferredStockMember 2022-12-31 0001381871 us-gaap:SeriesHPreferredStockMember 2023-09-30 0001381871 us-gaap:SeriesHPreferredStockMember 2022-12-31 0001381871 2022-01-01 2022-09-30 0001381871 2023-07-01 2023-09-30 0001381871 2022-07-01 2022-09-30 0001381871 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001381871 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001381871 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001381871 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001381871 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001381871 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001381871 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001381871 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001381871 us-gaap:CommonStockMember 2021-12-31 0001381871 bomo:CommonStockToBeIssuedMember 2021-12-31 0001381871 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001381871 us-gaap:TreasuryStockCommonMember 2021-12-31 0001381871 us-gaap:RetainedEarningsMember 2021-12-31 0001381871 2021-12-31 0001381871 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001381871 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001381871 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001381871 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001381871 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001381871 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001381871 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001381871 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001381871 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001381871 bomo:CommonStockToBeIssuedMember 2022-01-01 2022-03-31 0001381871 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001381871 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-03-31 0001381871 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001381871 2022-01-01 2022-03-31 0001381871 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0001381871 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0001381871 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0001381871 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0001381871 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0001381871 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0001381871 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0001381871 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0001381871 us-gaap:CommonStockMember 2022-03-31 0001381871 bomo:CommonStockToBeIssuedMember 2022-03-31 0001381871 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001381871 us-gaap:TreasuryStockCommonMember 2022-03-31 0001381871 us-gaap:RetainedEarningsMember 2022-03-31 0001381871 2022-03-31 0001381871 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001381871 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001381871 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001381871 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001381871 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001381871 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001381871 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001381871 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001381871 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001381871 bomo:CommonStockToBeIssuedMember 2022-04-01 2022-06-30 0001381871 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001381871 us-gaap:TreasuryStockCommonMember 2022-04-01 2022-06-30 0001381871 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001381871 2022-04-01 2022-06-30 0001381871 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-06-30 0001381871 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-06-30 0001381871 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2022-06-30 0001381871 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2022-06-30 0001381871 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2022-06-30 0001381871 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2022-06-30 0001381871 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2022-06-30 0001381871 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2022-06-30 0001381871 us-gaap:CommonStockMember 2022-06-30 0001381871 bomo:CommonStockToBeIssuedMember 2022-06-30 0001381871 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001381871 us-gaap:TreasuryStockCommonMember 2022-06-30 0001381871 us-gaap:RetainedEarningsMember 2022-06-30 0001381871 2022-06-30 0001381871 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0001381871 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0001381871 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0001381871 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0001381871 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0001381871 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0001381871 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0001381871 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0001381871 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001381871 bomo:CommonStockToBeIssuedMember 2022-07-01 2022-09-30 0001381871 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001381871 us-gaap:TreasuryStockCommonMember 2022-07-01 2022-09-30 0001381871 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001381871 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-09-30 0001381871 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-09-30 0001381871 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2022-09-30 0001381871 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2022-09-30 0001381871 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2022-09-30 0001381871 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2022-09-30 0001381871 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2022-09-30 0001381871 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2022-09-30 0001381871 us-gaap:CommonStockMember 2022-09-30 0001381871 bomo:CommonStockToBeIssuedMember 2022-09-30 0001381871 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001381871 us-gaap:TreasuryStockCommonMember 2022-09-30 0001381871 us-gaap:RetainedEarningsMember 2022-09-30 0001381871 2022-09-30 0001381871 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001381871 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001381871 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001381871 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001381871 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001381871 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001381871 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001381871 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001381871 us-gaap:CommonStockMember 2022-12-31 0001381871 bomo:CommonStockToBeIssuedMember 2022-12-31 0001381871 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001381871 us-gaap:TreasuryStockCommonMember 2022-12-31 0001381871 us-gaap:RetainedEarningsMember 2022-12-31 0001381871 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001381871 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001381871 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001381871 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001381871 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001381871 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001381871 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001381871 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001381871 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001381871 bomo:CommonStockToBeIssuedMember 2023-01-01 2023-03-31 0001381871 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001381871 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0001381871 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001381871 2023-01-01 2023-03-31 0001381871 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001381871 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001381871 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001381871 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001381871 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001381871 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001381871 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001381871 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001381871 us-gaap:CommonStockMember 2023-03-31 0001381871 bomo:CommonStockToBeIssuedMember 2023-03-31 0001381871 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001381871 us-gaap:TreasuryStockCommonMember 2023-03-31 0001381871 us-gaap:RetainedEarningsMember 2023-03-31 0001381871 2023-03-31 0001381871 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001381871 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001381871 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001381871 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001381871 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001381871 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001381871 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001381871 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001381871 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001381871 bomo:CommonStockToBeIssuedMember 2023-04-01 2023-06-30 0001381871 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001381871 us-gaap:TreasuryStockCommonMember 2023-04-01 2023-06-30 0001381871 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001381871 2023-04-01 2023-06-30 0001381871 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001381871 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001381871 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001381871 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001381871 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001381871 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001381871 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001381871 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001381871 us-gaap:CommonStockMember 2023-06-30 0001381871 bomo:CommonStockToBeIssuedMember 2023-06-30 0001381871 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001381871 us-gaap:TreasuryStockCommonMember 2023-06-30 0001381871 us-gaap:RetainedEarningsMember 2023-06-30 0001381871 2023-06-30 0001381871 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0001381871 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0001381871 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0001381871 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0001381871 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0001381871 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0001381871 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0001381871 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0001381871 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001381871 bomo:CommonStockToBeIssuedMember 2023-07-01 2023-09-30 0001381871 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001381871 us-gaap:TreasuryStockCommonMember 2023-07-01 2023-09-30 0001381871 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001381871 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-09-30 0001381871 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-09-30 0001381871 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2023-09-30 0001381871 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2023-09-30 0001381871 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2023-09-30 0001381871 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2023-09-30 0001381871 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2023-09-30 0001381871 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2023-09-30 0001381871 us-gaap:CommonStockMember 2023-09-30 0001381871 bomo:CommonStockToBeIssuedMember 2023-09-30 0001381871 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001381871 us-gaap:TreasuryStockCommonMember 2023-09-30 0001381871 us-gaap:RetainedEarningsMember 2023-09-30 0001381871 srt:ScenarioPreviouslyReportedMember 2023-09-30 0001381871 srt:RestatementAdjustmentMember 2023-09-30 0001381871 bomo:AsRestatedMember 2023-09-30 0001381871 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesHPreferredStockMember 2023-09-30 0001381871 srt:RestatementAdjustmentMember us-gaap:SeriesHPreferredStockMember 2023-09-30 0001381871 bomo:AsRestatedMember us-gaap:SeriesHPreferredStockMember 2023-09-30 0001381871 srt:ScenarioPreviouslyReportedMember 2022-12-31 0001381871 srt:RestatementAdjustmentMember 2022-12-31 0001381871 bomo:AsRestatedMember 2022-12-31 0001381871 srt:ScenarioPreviouslyReportedMember us-gaap:SeriesHPreferredStockMember 2022-12-31 0001381871 srt:RestatementAdjustmentMember us-gaap:SeriesHPreferredStockMember 2022-12-31 0001381871 bomo:AsRestatedMember us-gaap:SeriesHPreferredStockMember 2022-12-31 0001381871 bomo:AsPreviouslyReportedMember 2022-01-01 2022-09-30 0001381871 bomo:AdjustmentsMember 2022-01-01 2022-09-30 0001381871 bomo:AsRestatedMember 2022-01-01 2022-09-30 0001381871 bomo:ReverseAcquisitionMember bomo:BowmoMember us-gaap:SeriesGPreferredStockMember 2023-09-30 0001381871 us-gaap:CommonStockMember 2023-10-10 0001381871 2023-10-10 2023-10-10 0001381871 bomo:DirectPlacementMember srt:MinimumMember 2023-01-01 2023-09-30 0001381871 bomo:DirectPlacementMember srt:MaximumMember 2023-01-01 2023-09-30 0001381871 bomo:DirectPlacementMember 2023-09-30 0001381871 bomo:DirectPlacementMember 2022-12-31 0001381871 bomo:RevenueMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001381871 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001381871 bomo:MajorCustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001381871 bomo:MajorCustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001381871 bomo:MajorCustomerThreeMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001381871 bomo:MajorCustomerFourMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001381871 bomo:TwoMajorCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001381871 bomo:DirectPlacementMember 2023-07-01 2023-09-30 0001381871 bomo:DirectPlacementMember 2022-04-01 2022-09-30 0001381871 bomo:DirectPlacementMember 2023-01-01 2023-09-30 0001381871 bomo:DirectPlacementMember 2022-01-01 2022-09-30 0001381871 bomo:RecruitingAsAServiceMember 2023-07-01 2023-09-30 0001381871 bomo:RecruitingAsAServiceMember 2022-04-01 2022-09-30 0001381871 bomo:RecruitingAsAServiceMember 2023-01-01 2023-09-30 0001381871 bomo:RecruitingAsAServiceMember 2022-01-01 2022-09-30 0001381871 2022-04-01 2022-09-30 0001381871 bomo:AssetPurchaseAgreementMember bomo:InterviewMasteryAcquisitionMember 2022-12-16 2022-12-16 0001381871 bomo:AssetPurchaseAgreementMember bomo:InterviewMasteryAcquisitionMember 2022-12-16 0001381871 2022-12-16 0001381871 bomo:AssetPurchaseAgreementMember bomo:MichaelR.NeeceMember 2022-12-16 2022-12-16 0001381871 bomo:AssetPurchaseAgreementMember bomo:MichaelR.NeeceMember bomo:ShareBasedCompensationAwardOneToFourMember 2022-12-16 0001381871 bomo:AssetPurchaseAgreementMember bomo:MichaelR.NeeceMember bomo:ShareBasedCompensationAwardTranchePerQuarterMember 2022-12-16 0001381871 bomo:AssetPurchaseAgreementMember bomo:MichaelR.NeeceMember 2022-12-16 0001381871 2022-01-01 2022-12-31 0001381871 bomo:InterviewMasteryAcquisitionMember 2021-01-01 2021-12-31 0001381871 2021-01-01 2021-12-31 0001381871 bomo:InterviewMasteryAcquisitionMember 2022-01-01 2022-12-17 0001381871 2022-01-01 2022-12-17 0001381871 bomo:InterviewMasteryAcquisitionMember 2023-01-01 2023-09-30 0001381871 bomo:InterviewMasteryAcquisitionMember 2023-09-30 0001381871 bomo:LoanOneMember 2013-05-30 2013-05-30 0001381871 bomo:LoanOneMember 2013-08-12 2013-08-12 0001381871 bomo:LoanOneMember 2013-08-12 0001381871 bomo:LoanOneMember 2023-09-30 0001381871 bomo:Loan2Member 2014-02-27 2014-02-27 0001381871 bomo:Loan2Member 2015-03-19 2015-03-19 0001381871 bomo:Loan2Member 2015-12-31 2015-12-31 0001381871 bomo:Loan2Member 2023-09-30 0001381871 bomo:Loan3Member 2014-09-18 2014-09-18 0001381871 bomo:Loan3Member 2015-05-29 2015-05-29 0001381871 bomo:Loan3Member 2015-07-03 2015-07-03 0001381871 bomo:Loan3Member 2015-12-02 2015-12-02 0001381871 bomo:Loan3Member 2016-01-04 2016-01-04 0001381871 bomo:Loan3Member 2023-09-30 0001381871 bomo:Loan4Member 2014-12-04 2014-12-04 0001381871 bomo:Loan4Member 2015-01-29 2015-01-29 0001381871 bomo:Loan4Member 2015-08-12 2015-08-12 0001381871 bomo:Loan4Member 2015-08-21 2015-08-21 0001381871 bomo:Loan4Member 2015-09-01 2015-09-01 0001381871 bomo:Loan4Member 2015-09-15 2015-09-15 0001381871 bomo:Loan4Member 2015-11-13 2015-11-13 0001381871 bomo:Loan4Member 2015-12-23 2015-12-23 0001381871 bomo:Loan4Member 2023-09-30 0001381871 bomo:Loan5Member bomo:UnitedStatesSmallBusinessAdministrationMember 2020-07-15 2020-07-15 0001381871 bomo:Loan5Member bomo:UnitedStatesSmallBusinessAdministrationMember 2020-07-01 2020-07-31 0001381871 bomo:Loan5Member 2020-07-15 0001381871 bomo:Loan5Member 2023-01-01 2023-09-30 0001381871 bomo:Loan5Member 2021-12-31 0001381871 bomo:Loan5Member 2021-01-01 2021-12-31 0001381871 bomo:Loan5Member 2022-02-01 2022-02-28 0001381871 srt:MinimumMember bomo:Loan5Member 2022-02-01 2022-02-28 0001381871 bomo:Loan1Member 2023-09-30 0001381871 bomo:Loan1Member 2022-12-31 0001381871 bomo:Loan2Member 2023-09-30 0001381871 bomo:Loan2Member 2022-12-31 0001381871 bomo:Loan3Member 2023-09-30 0001381871 bomo:Loan3Member 2022-12-31 0001381871 bomo:Loan4Member 2023-09-30 0001381871 bomo:Loan4Member 2022-12-31 0001381871 bomo:Loan5Member 2023-09-30 0001381871 bomo:Loan5Member 2022-12-31 0001381871 bomo:TravelDataSolutionsMember 2017-11-18 0001381871 bomo:TravelDataSolutionsMember 2017-11-18 2017-11-18 0001381871 bomo:TravelDataSolutionsMember 2018-01-01 2018-01-31 0001381871 bomo:TravelDataSolutionsMember 2018-02-01 2018-02-28 0001381871 bomo:TravelDataSolutionsMember 2023-09-30 0001381871 bomo:TravelDataSolutionsMember 2022-12-31 0001381871 bomo:TravelDataSolutionsOneMember 2019-01-18 0001381871 bomo:TravelDataSolutionsOneMember 2019-01-18 2019-01-18 0001381871 bomo:TravelDataSolutionsOneMember 2023-09-30 0001381871 bomo:TravelDataSolutionsOneMember 2022-12-31 0001381871 bomo:ThirdPartyMember 2020-07-07 0001381871 bomo:ThirdPartyMember 2020-07-07 2020-07-07 0001381871 srt:MinimumMember bomo:TrilliumPartnersLpMember 2022-06-15 2022-06-15 0001381871 srt:MaximumMember bomo:TrilliumPartnersLpMember 2023-01-01 2023-09-30 0001381871 bomo:TrilliumPartnersLpMember 2022-06-15 2022-06-15 0001381871 bomo:TrilliumPartnersLpMember 2023-01-01 2023-09-30 0001381871 bomo:TrilliumPartnersLpMember 2022-01-01 2022-12-31 0001381871 bomo:TrilliumPartnersLpMember 2023-09-30 0001381871 bomo:TrilliumPartnersLpMember 2022-12-31 0001381871 bomo:FrondeurPartnersLLCMember 2022-06-01 2022-06-01 0001381871 bomo:FrondeurPartnersLLCMember 2023-01-01 2023-09-30 0001381871 srt:MinimumMember bomo:FrondeurPartnersLLCMember 2022-06-01 2022-06-01 0001381871 srt:MaximumMember bomo:FrondeurPartnersLLCMember 2023-01-01 2023-09-30 0001381871 bomo:FrondeurPartnersLLCMember 2023-09-30 0001381871 bomo:FrondeurPartnersLLCMember 2022-12-31 0001381871 bomo:TrilliumPartnersLpMember 2022-10-19 2022-10-19 0001381871 bomo:TrilliumPartnersLpMember 2022-10-19 0001381871 bomo:MrAizmanAndMrLakshinMember us-gaap:SeriesGPreferredStockMember 2022-10-19 0001381871 bomo:ConvertibleNotesMember us-gaap:SeriesGPreferredStockMember 2022-10-19 0001381871 bomo:MrAizmanAndMrLakshinMember 2023-09-30 0001381871 bomo:MrAizmanAndMrLakshinMember 2022-12-31 0001381871 bomo:KingWharfOpportunitiesFundMember 2022-10-19 2022-10-19 0001381871 bomo:KingWharfOpportunitiesFundMember 2022-10-19 0001381871 bomo:MrAizmanAndMrLakshinMember 2022-10-19 0001381871 bomo:KingWharfOpportunitiesFundMember us-gaap:SeriesGPreferredStockMember 2022-10-19 0001381871 bomo:KingWharfOpportunitiesFundMember 2023-09-30 0001381871 bomo:KingWharfOpportunitiesFundMember 2022-12-31 0001381871 bomo:MatterhornPartnersLLCMember 2023-08-15 2023-08-15 0001381871 bomo:MatterhornPartnersLLCMember 2023-08-15 0001381871 bomo:TravelDataSolutionsIncMember 2023-01-01 2023-09-30 0001381871 bomo:TravelDataSolutionsIncMember 2023-09-30 0001381871 bomo:TravelDataSolutionsIncMember 2022-12-31 0001381871 bomo:TravelDataSolutionsInc1OneMember 2023-01-01 2023-09-30 0001381871 bomo:TravelDataSolutionsInc1OneMember 2023-09-30 0001381871 bomo:TravelDataSolutionsInc1OneMember 2022-12-31 0001381871 bomo:ThirdPartyMember 2023-01-01 2023-09-30 0001381871 bomo:ThirdPartyMember 2023-09-30 0001381871 bomo:ThirdPartyMember 2022-12-31 0001381871 bomo:TrilliumPartnersLpMember 2023-01-01 2023-09-30 0001381871 bomo:TrilliumPartnersLpMember 2023-09-30 0001381871 bomo:TrilliumPartnersLpMember 2022-12-31 0001381871 bomo:TrilliumPartnersLPOneMember 2023-01-01 2023-09-30 0001381871 bomo:TrilliumPartnersLPOneMember 2023-09-30 0001381871 bomo:TrilliumPartnersLPOneMember 2022-12-31 0001381871 bomo:FrondeurPartnersLLCMember 2023-01-01 2023-09-30 0001381871 bomo:FrondeurPartnersLLCMember 2023-09-30 0001381871 bomo:FrondeurPartnersLLCMember 2022-12-31 0001381871 bomo:FrondeurPartnersLLCOneMember 2023-01-01 2023-09-30 0001381871 bomo:FrondeurPartnersLLCOneMember 2023-09-30 0001381871 bomo:FrondeurPartnersLLCOneMember 2022-12-31 0001381871 bomo:TrilliumPartnersLP4TwoMember 2023-01-01 2023-09-30 0001381871 bomo:TrilliumPartnersLP4TwoMember 2023-09-30 0001381871 bomo:TrilliumPartnersLP4TwoMember 2022-12-31 0001381871 bomo:KingWharfOpportunitiesFundMember 2023-01-01 2023-09-30 0001381871 bomo:KingWharfOpportunitiesFundMember 2023-09-30 0001381871 bomo:KingWharfOpportunitiesFundMember 2022-12-31 0001381871 bomo:TrilliumPartnersLP4ThreeMember 2023-01-01 2023-09-30 0001381871 bomo:TrilliumPartnersLP4ThreeMember 2023-09-30 0001381871 bomo:TrilliumPartnersLP4ThreeMember 2022-12-31 0001381871 bomo:TrilliumPartnersLPFourMember 2023-01-01 2023-09-30 0001381871 bomo:TrilliumPartnersLPFourMember 2023-09-30 0001381871 bomo:TrilliumPartnersLPFourMember 2022-12-31 0001381871 bomo:FrondeurPartnersLLC5TwoMember 2023-01-01 2023-09-30 0001381871 bomo:FrondeurPartnersLLC5TwoMember 2023-09-30 0001381871 bomo:FrondeurPartnersLLC5TwoMember 2022-12-31 0001381871 bomo:FrondeurPartnersLLC5ThreeMember 2023-01-01 2023-09-30 0001381871 bomo:FrondeurPartnersLLC5ThreeMember 2023-09-30 0001381871 bomo:FrondeurPartnersLLC5ThreeMember 2022-12-31 0001381871 bomo:FrondeurPartnersLLC5FourMember 2023-01-01 2023-09-30 0001381871 bomo:FrondeurPartnersLLC5FourMember 2023-09-30 0001381871 bomo:FrondeurPartnersLLC5FourMember 2022-12-31 0001381871 bomo:FrondeurPartnersLlcFiveMember 2023-01-01 2023-09-30 0001381871 bomo:FrondeurPartnersLlcFiveMember 2023-09-30 0001381871 bomo:FrondeurPartnersLlcFiveMember 2022-12-31 0001381871 bomo:FrondeurPartnersLlcSixMember 2023-01-01 2023-09-30 0001381871 bomo:FrondeurPartnersLlcSixMember 2023-09-30 0001381871 bomo:FrondeurPartnersLlcSixMember 2022-12-31 0001381871 bomo:TrilliumPartnersLPFiveMember 2023-01-01 2023-09-30 0001381871 bomo:TrilliumPartnersLPFiveMember 2023-09-30 0001381871 bomo:TrilliumPartnersLPFiveMember 2022-12-31 0001381871 bomo:FrondeurPartnersLlcSevenMember 2023-01-01 2023-09-30 0001381871 bomo:FrondeurPartnersLlcSevenMember 2023-09-30 0001381871 bomo:FrondeurPartnersLlcSevenMember 2022-12-31 0001381871 bomo:FrondeurPartnersLLCEightMember 2023-01-01 2023-09-30 0001381871 bomo:FrondeurPartnersLLCEightMember 2023-09-30 0001381871 bomo:FrondeurPartnersLLCEightMember 2022-12-31 0001381871 bomo:FrondeurPartnersLLCNineMember 2023-01-01 2023-09-30 0001381871 bomo:FrondeurPartnersLLCNineMember 2023-09-30 0001381871 bomo:FrondeurPartnersLLCNineMember 2022-12-31 0001381871 bomo:FrondeurPartnersLLCTenMember 2023-01-01 2023-09-30 0001381871 bomo:FrondeurPartnersLLCTenMember 2023-09-30 0001381871 bomo:FrondeurPartnersLLCTenMember 2022-12-31 0001381871 bomo:TrilliumPartnersLPSixMember 2023-01-01 2023-09-30 0001381871 bomo:TrilliumPartnersLPSixMember 2023-09-30 0001381871 bomo:TrilliumPartnersLPSixMember 2022-12-31 0001381871 bomo:TrilliumPartnersLPSevenMember 2023-01-01 2023-09-30 0001381871 bomo:TrilliumPartnersLPSevenMember 2023-09-30 0001381871 bomo:TrilliumPartnersLPSevenMember 2022-12-31 0001381871 bomo:FrondeurPartnersLLCElevenMember 2023-01-01 2023-09-30 0001381871 bomo:FrondeurPartnersLLCElevenMember 2023-09-30 0001381871 bomo:FrondeurPartnersLLCElevenMember 2022-12-31 0001381871 bomo:MatterhornPartnersLLCMember 2023-01-01 2023-09-30 0001381871 bomo:MatterhornPartnersLLCMember 2023-09-30 0001381871 bomo:MatterhornPartnersLLCMember 2022-12-31 0001381871 bomo:FrondeurPartnersLLCTwelveMember 2023-01-01 2023-09-30 0001381871 bomo:FrondeurPartnersLLCTwelveMember 2023-09-30 0001381871 bomo:FrondeurPartnersLLCTwelveMember 2022-12-31 0001381871 bomo:FrondeurPartnersLLC5OneMember 2023-01-01 2023-09-30 0001381871 bomo:FrondeurPartnersLLC5OneMember 2023-09-30 0001381871 bomo:FrondeurPartnersLLC5FiveMember 2023-01-01 2023-09-30 0001381871 bomo:FrondeurPartnersLLC5FiveMember 2023-09-30 0001381871 bomo:FrondeurPartnersLLC5SixMember 2023-01-01 2023-09-30 0001381871 bomo:FrondeurPartnersLLC5SixMember 2023-09-30 0001381871 bomo:FrondeurPartnersLLC5SevenMember 2023-01-01 2023-09-30 0001381871 bomo:FrondeurPartnersLLC5SevenMember 2023-09-30 0001381871 bomo:FrondeurPartnersLLC5NineMember 2023-01-01 2023-09-30 0001381871 bomo:FrondeurPartnersLLC5NineMember 2023-09-30 0001381871 bomo:DebitDiscountMember 2023-01-01 2023-09-30 0001381871 bomo:DebitDiscountMember 2023-09-30 0001381871 us-gaap:ConvertibleNotesPayableMember 2023-01-01 2023-09-30 0001381871 us-gaap:ConvertibleNotesPayableMember 2023-09-30 0001381871 srt:MinimumMember 2023-09-30 0001381871 srt:MaximumMember 2023-09-30 0001381871 srt:MinimumMember 2022-12-31 0001381871 srt:MaximumMember 2022-12-31 0001381871 srt:MinimumMember 2023-01-01 2023-09-30 0001381871 srt:MaximumMember 2023-01-01 2023-09-30 0001381871 srt:MinimumMember 2022-01-01 2022-12-31 0001381871 srt:MaximumMember 2022-01-01 2022-12-31 0001381871 us-gaap:CommonStockMember 2023-09-30 0001381871 bomo:InterviewMasteryAcquisitionMember 2022-12-16 2022-12-16 0001381871 bomo:InterviewMasteryAcquisitionMember bomo:MichaelR.NeeceMember 2022-12-16 2022-12-16 0001381871 bomo:MichaelR.NeeceMember 2022-12-16 2022-12-16 0001381871 srt:ChiefExecutiveOfficerMember bomo:MichaelR.NeeceMember bomo:ShareBasedCompensationAwardTrancheOneToFourMember 2022-12-16 0001381871 bomo:MichaelR.NeeceMember bomo:ShareBasedCompensationAwardTranchePerQuarterMember 2022-12-16 0001381871 bomo:MichaelR.NeeceMember 2022-12-16 0001381871 bomo:MichaelR.NeeceMember 2023-07-01 2023-09-30 0001381871 bomo:MichaelR.NeeceMember 2023-01-01 2023-09-30 0001381871 bomo:TrilliumPartnersLpOneMember 2023-01-01 2023-09-30 0001381871 bomo:TrilliumPartnersLpOneMember 2023-09-30 0001381871 bomo:TrilliumPartnersLpTwoMember 2023-01-01 2023-09-30 0001381871 bomo:TrilliumPartnersLpTwoMember 2023-09-30 0001381871 bomo:FrondeurPartnersLLCTwoMember 2023-01-01 2023-09-30 0001381871 bomo:FrondeurPartnersLLCTwoMember 2023-09-30 0001381871 us-gaap:WarrantMember 2022-12-31 0001381871 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001381871 us-gaap:WarrantMember 2023-09-30 0001381871 bomo:SeriesAAAndSuperConvertiblePreferredStockMember 2023-09-30 0001381871 bomo:SeriesAaAndSuperPreferredStockMember 2023-09-30 0001381871 bomo:SeriesAaAndSuperPreferredStockMember 2022-12-31 0001381871 bomo:SeriesAConvertiblePreferredStockMember 2023-09-30 0001381871 bomo:SeriesBConvertiblePreferredStockMember 2023-09-30 0001381871 bomo:SeriesCConvertiblePreferredStockMember 2023-09-30 0001381871 us-gaap:SeriesDPreferredStockMember 2023-01-01 2023-09-30 0001381871 bomo:SeriesDConvertiblePreferredStockMember 2023-09-30 0001381871 bomo:SeriesDConvertiblePreferredStockMember 2022-12-31 0001381871 bomo:SeriesEConvertiblePreferredStockMember 2023-09-30 0001381871 us-gaap:SeriesFPreferredStockMember 2023-01-01 2023-09-30 0001381871 us-gaap:SeriesFPreferredStockMember 2023-09-30 0001381871 us-gaap:SeriesFPreferredStockMember 2022-12-31 0001381871 us-gaap:SeriesGPreferredStockMember 2023-01-01 2023-09-30 0001381871 bomo:SeriesHConvertiblePreferredStockMember 2023-09-30 0001381871 bomo:EddieAizmanMember 2022-01-01 2022-12-31 0001381871 bomo:MichaelLakshinMember 2022-01-01 2022-12-31 0001381871 bomo:ConradHussMember 2019-07-08 2019-07-08 0001381871 bomo:ConradHussMember 2023-09-30 0001381871 bomo:DamianHischierMember 2023-01-01 2023-09-30 0001381871 bomo:DamianHischierMember 2023-09-30 0001381871 bomo:KeithCarlsonMember 2023-01-01 2023-09-30 0001381871 bomo:KeithCarlsonMember 2023-09-30 0001381871 2017-02-13 2017-02-13 0001381871 us-gaap:SubsequentEventMember 2023-10-10 0001381871 us-gaap:SubsequentEventMember 2023-10-10 2023-10-10 0001381871 us-gaap:SubsequentEventMember 2023-11-20 0001381871 us-gaap:SubsequentEventMember 2023-11-01 2023-11-20 0001381871 srt:ScenarioForecastMember 2024-08-31 0001381871 srt:ScenarioForecastMember 2024-09-30 0001381871 srt:MinimumMember bomo:ConvertibleNotesMember us-gaap:SubsequentEventMember 2023-11-14 2023-11-14 0001381871 srt:MaximumMember bomo:ConvertibleNotesMember us-gaap:SubsequentEventMember 2023-11-14 2023-11-14 0001381871 bomo:ConvertibleNotesMember us-gaap:SubsequentEventMember 2023-11-14 0001381871 us-gaap:SubsequentEventMember 2023-10-18 2023-11-15 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

NONE false --12-31 Q1 0001381871 0001381871 2024-01-01 2024-03-31 0001381871 2024-10-11 0001381871 2024-03-31 0001381871 2023-12-31 0001381871 us-gaap:RelatedPartyMember 2024-03-31 0001381871 us-gaap:RelatedPartyMember 2023-12-31 0001381871 us-gaap:SeriesAPreferredStockMember 2024-03-31 0001381871 us-gaap:SeriesAPreferredStockMember 2023-12-31 0001381871 us-gaap:SeriesBPreferredStockMember 2024-03-31 0001381871 us-gaap:SeriesBPreferredStockMember 2023-12-31 0001381871 us-gaap:SeriesCPreferredStockMember 2024-03-31 0001381871 us-gaap:SeriesCPreferredStockMember 2023-12-31 0001381871 us-gaap:SeriesDPreferredStockMember 2024-03-31 0001381871 us-gaap:SeriesDPreferredStockMember 2023-12-31 0001381871 us-gaap:SeriesEPreferredStockMember 2024-03-31 0001381871 us-gaap:SeriesEPreferredStockMember 2023-12-31 0001381871 us-gaap:SeriesFPreferredStockMember 2024-03-31 0001381871 us-gaap:SeriesFPreferredStockMember 2023-12-31 0001381871 us-gaap:SeriesGPreferredStockMember 2024-03-31 0001381871 us-gaap:SeriesGPreferredStockMember 2023-12-31 0001381871 us-gaap:SeriesHPreferredStockMember 2023-12-31 0001381871 us-gaap:SeriesHPreferredStockMember 2024-03-31 0001381871 bomo:SeriesAAPreferredStockMember 2024-03-31 0001381871 bomo:SeriesAAPreferredStockMember 2023-12-31 0001381871 bomo:SeriesSuperPreferredStockMember 2024-03-31 0001381871 bomo:SeriesSuperPreferredStockMember 2023-12-31 0001381871 us-gaap:CommonStockMember 2024-03-31 0001381871 us-gaap:CommonStockMember 2023-12-31 0001381871 2023-01-01 2023-03-31 0001381871 bomo:PreferredStockAAMember us-gaap:PreferredStockMember 2022-12-31 0001381871 bomo:SuperPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001381871 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001381871 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001381871 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001381871 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001381871 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001381871 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001381871 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001381871 us-gaap:CommonStockMember 2022-12-31 0001381871 bomo:CommonStockToBeIssuedMember 2022-12-31 0001381871 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001381871 us-gaap:TreasuryStockCommonMember 2022-12-31 0001381871 us-gaap:RetainedEarningsMember 2022-12-31 0001381871 2022-12-31 0001381871 bomo:PreferredStockAAMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001381871 bomo:SuperPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001381871 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001381871 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001381871 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001381871 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001381871 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001381871 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001381871 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001381871 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001381871 bomo:CommonStockToBeIssuedMember 2023-01-01 2023-03-31 0001381871 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001381871 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0001381871 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001381871 bomo:PreferredStockAAMember us-gaap:PreferredStockMember 2023-03-31 0001381871 bomo:SuperPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001381871 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001381871 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001381871 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001381871 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001381871 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001381871 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001381871 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001381871 us-gaap:CommonStockMember 2023-03-31 0001381871 bomo:CommonStockToBeIssuedMember 2023-03-31 0001381871 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001381871 us-gaap:TreasuryStockCommonMember 2023-03-31 0001381871 us-gaap:RetainedEarningsMember 2023-03-31 0001381871 2023-03-31 0001381871 bomo:PreferredStockAAMember us-gaap:PreferredStockMember 2023-12-31 0001381871 bomo:SuperPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001381871 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001381871 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001381871 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001381871 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001381871 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001381871 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001381871 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001381871 us-gaap:CommonStockMember 2023-12-31 0001381871 bomo:CommonStockToBeIssuedMember 2023-12-31 0001381871 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001381871 us-gaap:TreasuryStockCommonMember 2023-12-31 0001381871 us-gaap:RetainedEarningsMember 2023-12-31 0001381871 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001381871 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001381871 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001381871 bomo:PreferredStockAAMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001381871 bomo:SuperPreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001381871 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001381871 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001381871 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001381871 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001381871 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001381871 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001381871 bomo:CommonStockToBeIssuedMember 2024-01-01 2024-03-31 0001381871 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0001381871 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001381871 bomo:PreferredStockAAMember us-gaap:PreferredStockMember 2024-03-31 0001381871 bomo:SuperPreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001381871 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001381871 us-gaap:SeriesBPreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001381871 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001381871 us-gaap:SeriesDPreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001381871 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001381871 us-gaap:SeriesGPreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001381871 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001381871 us-gaap:CommonStockMember 2024-03-31 0001381871 bomo:CommonStockToBeIssuedMember 2024-03-31 0001381871 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001381871 us-gaap:TreasuryStockCommonMember 2024-03-31 0001381871 us-gaap:RetainedEarningsMember 2024-03-31 0001381871 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:SeriesGPreferredStockMember 2024-03-31 0001381871 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2024-03-31 0001381871 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:SeriesAPreferredStockMember 2024-03-31 0001381871 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:SeriesBPreferredStockMember 2024-03-31 0001381871 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:SeriesCPreferredStockMember 2024-03-31 0001381871 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:SeriesDPreferredStockMember 2024-03-31 0001381871 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:SeriesEPreferredStockMember 2024-03-31 0001381871 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:SeriesFPreferredStockMember 2024-03-31 0001381871 2023-01-01 2023-12-31 0001381871 2022-01-01 2022-12-31 0001381871 bomo:DirectPlacementMember srt:MinimumMember 2024-01-01 2024-03-31 0001381871 bomo:DirectPlacementMember srt:MaximumMember 2024-01-01 2024-03-31 0001381871 bomo:DirectPlacementMember 2024-01-01 2024-03-31 0001381871 bomo:DirectPlacementMember 2023-01-01 2023-12-31 0001381871 bomo:RecruitingAsAServiceMember 2024-01-01 2024-03-31 0001381871 bomo:RecruitingAsAServiceMember 2023-01-01 2023-12-31 0001381871 us-gaap:CommonStockMember 2022-12-16 2022-12-16 0001381871 bomo:AssetPurchaseAgreementMember bomo:InterviewMasteryAcquisitionMember 2022-12-16 0001381871 bomo:InterviewMasteryAcquisitionMember us-gaap:CommonStockMember 2022-12-16 2022-12-16 0001381871 bomo:AssetPurchaseAgreementMember bomo:MichaelRNeeceMember 2022-12-16 2022-12-16 0001381871 bomo:AssetPurchaseAgreementMember 2022-12-16 2022-12-16 0001381871 bomo:AssetPurchaseAgreementMember bomo:MichaelRNeeceMember 2022-12-16 0001381871 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-12-31 0001381871 bomo:InterviewMasteryAcquisitionMember 2024-01-01 2024-03-31 0001381871 2021-01-01 2021-12-31 0001381871 bomo:LoanOneMember bomo:CruzaniMember 2013-05-30 2013-05-30 0001381871 bomo:LoanOneMember bomo:CruzaniMember 2013-08-12 2013-08-12 0001381871 bomo:LoanOneMember 2013-08-12 2013-08-12 0001381871 bomo:LoanOneMember 2024-03-31 0001381871 bomo:Loan2Member 2014-02-27 2014-02-27 0001381871 bomo:Loan2Member 2015-03-19 2015-03-19 0001381871 bomo:Loan2Member 2015-12-31 2015-12-31 0001381871 bomo:Loan2Member 2024-03-31 0001381871 bomo:Loan3Member 2014-09-18 2014-09-18 0001381871 bomo:Loan3Member 2015-05-29 2015-05-29 0001381871 bomo:Loan3Member 2015-07-03 2015-07-03 0001381871 bomo:Loan3Member 2015-12-02 2015-12-02 0001381871 bomo:Loan3Member 2016-01-04 2016-01-04 0001381871 bomo:Loan3Member 2024-03-31 0001381871 bomo:Loan4Member 2014-12-04 2014-12-04 0001381871 bomo:Loan4Member 2015-01-29 2015-01-29 0001381871 bomo:Loan4Member 2015-08-12 2015-08-12 0001381871 bomo:Loan4Member 2015-08-21 2015-08-21 0001381871 bomo:Loan4Member 2015-09-01 2015-09-01 0001381871 bomo:Loan4Member 2015-09-15 2015-09-15 0001381871 bomo:Loan4Member 2015-11-13 2015-11-13 0001381871 bomo:Loan4Member 2015-12-23 2015-12-23 0001381871 bomo:Loan4Member 2024-03-31 0001381871 bomo:Loan5Member bomo:UnitedStatesSmallBusinessAdministrationMember 2020-07-15 2020-07-15 0001381871 bomo:EDILAdvanceMember bomo:UnitedStatesSmallBusinessAdministrationMember 2020-07-01 2020-07-31 0001381871 bomo:Loan5Member 2020-07-15 0001381871 bomo:Loan5Member 2024-01-01 2024-03-31 0001381871 bomo:Loan5Member 2021-12-31 0001381871 bomo:Loan5Member 2021-01-01 2021-12-31 0001381871 bomo:Loan5Member 2022-02-01 2022-02-28 0001381871 srt:MaximumMember bomo:Loan5Member 2022-02-01 2022-02-28 0001381871 srt:MinimumMember bomo:Loan5Member 2022-02-01 2022-02-28 0001381871 bomo:EIDLLoanMember 2024-03-31 0001381871 bomo:EIDLLoanMember 2023-12-31 0001381871 bomo:LoanOneMember 2024-01-01 2024-03-31 0001381871 bomo:LoanOneMember 2024-03-31 0001381871 bomo:LoanOneMember 2023-12-31 0001381871 bomo:Loan2Member 2024-01-01 2024-03-31 0001381871 bomo:Loan2Member 2024-03-31 0001381871 bomo:Loan2Member 2023-12-31 0001381871 bomo:Loan3Member 2024-01-01 2024-03-31 0001381871 bomo:Loan3Member 2024-03-31 0001381871 bomo:Loan3Member 2023-12-31 0001381871 bomo:Loan4Member 2024-01-01 2024-03-31 0001381871 bomo:Loan4Member 2024-03-31 0001381871 bomo:Loan4Member 2023-12-31 0001381871 bomo:Loan5Member 2024-01-01 2024-03-31 0001381871 bomo:Loan5Member 2024-03-31 0001381871 bomo:Loan5Member 2023-12-31 0001381871 bomo:CruzaniMember 2024-03-31 0001381871 bomo:FrondeurMember 2022-12-01 0001381871 bomo:FrondeurMember 2022-12-01 0001381871 srt:MinimumMember bomo:FrondeurMember 2022-06-01 2022-12-01 0001381871 srt:MaximumMember bomo:FrondeurMember 2022-06-01 2022-12-01 0001381871 bomo:ConvertibleNotesMember 2024-03-31 0001381871 bomo:ConvertibleNotesMember 2023-12-31 0001381871 bomo:FrondeurPartnersLLCMember 2022-05-01 0001381871 srt:MinimumMember bomo:TwoConvertibleNotesMember 2022-05-01 2022-05-01 0001381871 bomo:FrondeurPartnersLLCMember 2024-03-31 0001381871 2024-01-01 0001381871 2024-02-01 0001381871 2024-03-01 0001381871 bomo:FrondeurPartnersLLCMember 2023-12-31 0001381871 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001381871 bomo:KingWharfOpportunitiesFundMember 2022-10-19 0001381871 bomo:KingsWharfMember 2022-10-19 2022-10-19 0001381871 bomo:KingWharfOpportunitiesFundMember 2022-10-19 2022-10-19 0001381871 bomo:KingsWharfMember us-gaap:SeriesGPreferredStockMember 2022-10-19 0001381871 bomo:KingWharfOpportunitiesFundMember us-gaap:SeriesGPreferredStockMember 2022-10-19 0001381871 bomo:KingsWharfMember 2024-03-31 0001381871 bomo:KingsWharfMember 2023-12-31 0001381871 bomo:DiagonalLendingMember 2023-11-10 0001381871 bomo:DiagonalLendingMember 2023-11-10 0001381871 bomo:DiagonalLendingMember 2023-11-10 2023-11-10 0001381871 bomo:DiagonalLendingMember bomo:ConvertibleNotesMember 2024-03-31 0001381871 bomo:DiagonalLendingMember bomo:ConvertibleNotesMember 2023-12-31 0001381871 bomo:DiagonalLendingMember 2023-12-12 0001381871 bomo:DiagonalLendingMember 2023-12-12 2023-12-12 0001381871 bomo:DiagonalLendingOneMember 2024-03-31 0001381871 bomo:DiagonalLendingOneMember 2023-12-31 0001381871 bomo:TwoConvertibleNotesMember bomo:TrilliumPartnersLpMember 2021-07-06 0001381871 bomo:TrilliumPartnersLpMember 2024-03-31 0001381871 bomo:TrilliumPartnersLpMember 2023-12-31 0001381871 srt:MinimumMember bomo:SeveralConvertibleNotesMember bomo:TrilliumPartnersLpMember 2022-12-06 0001381871 srt:MaximumMember bomo:SeveralConvertibleNotesMember bomo:TrilliumPartnersLpMember 2022-12-06 0001381871 bomo:SeveralConvertibleNotesMember bomo:TrilliumPartnersLpMember 2022-12-06 0001381871 srt:MinimumMember bomo:SeveralConvertibleNotesMember bomo:TrilliumPartnersLpMember 2022-06-01 2022-12-06 0001381871 srt:MaximumMember bomo:SeveralConvertibleNotesMember bomo:TrilliumPartnersLpMember 2022-06-01 2022-12-06 0001381871 bomo:TrilliumPartnersLPOneMember 2024-03-31 0001381871 bomo:TrilliumPartnersLPOneMember 2023-12-31 0001381871 bomo:TrilliumPartnersLpMember 2022-10-19 2022-10-19 0001381871 bomo:TrilliumPartnersLpMember 2022-10-19 0001381871 2022-10-19 0001381871 bomo:TrilliumPartnersLpMember 2022-10-19 2022-10-19 0001381871 bomo:MrAizmanAndMrLakshinMember us-gaap:SeriesGPreferredStockMember 2022-10-19 0001381871 bomo:ConvertibleNotesMember us-gaap:SeriesGPreferredStockMember 2022-10-19 0001381871 bomo:TrilliumPartnersLPTwoMember 2024-03-31 0001381871 bomo:TrilliumPartnersLPTwoMember 2023-12-31 0001381871 bomo:MatterhornPartnersLLCMember 2023-08-15 2023-08-15 0001381871 bomo:MatterhornPartnersLLCMember 2023-08-15 0001381871 bomo:TrilliumPartnersLpMember 2023-08-15 0001381871 bomo:MatterhornMember 2023-08-15 2023-08-15 0001381871 bomo:MatterhornPartnersLLCMember 2024-03-31 0001381871 bomo:MatterhornPartnersLLCMember 2023-12-31 0001381871 bomo:ConvertiblePromissoryNoteMember bomo:TravelDataSolutionsMember 2017-11-18 0001381871 bomo:TravelDataSolutionsMember 2017-11-18 2017-11-18 0001381871 bomo:TravelDataSolutionsMember 2018-01-01 2018-01-31 0001381871 bomo:TravelDataSolutionsMember 2018-02-01 2018-02-28 0001381871 bomo:TravelDataSolutionsMember 2024-03-31 0001381871 bomo:TravelDataSolutionsMember 2023-12-31 0001381871 2021-10-01 2021-10-01 0001381871 2021-10-01 0001381871 bomo:TwoConvertibleNotesMember 2021-10-01 2021-10-01 0001381871 2021-11-17 2021-11-17 0001381871 2021-11-17 0001381871 bomo:TwoConvertibleNotesMember 2021-11-17 2021-11-17 0001381871 bomo:ThirdPartyMember 2020-07-07 2020-07-07 0001381871 bomo:ThirdPartyMember 2020-07-07 0001381871 bomo:ThirdPartyMember 2024-03-31 0001381871 bomo:ThirdPartyMember 2023-12-31 0001381871 bomo:FrondeurMember 2024-03-31 0001381871 bomo:FrondeurMember 2023-12-31 0001381871 bomo:PremiumOnStockSettledDebtMember bomo:FrondeurMember 2024-03-31 0001381871 bomo:PremiumOnStockSettledDebtMember bomo:KingsWharfMember 2024-03-31 0001381871 bomo:DiagonalLendingMember 2024-03-31 0001381871 bomo:DiagonalLendingMember 2023-12-31 0001381871 bomo:PremiumOnStockSettledDebtMember bomo:DiagonalLendingMember 2024-03-31 0001381871 bomo:TrilliumMember 2024-03-31 0001381871 bomo:TrilliumMember 2023-12-31 0001381871 bomo:PremiumOnStockSettledDebtMember bomo:TrilliumMember 2024-03-31 0001381871 bomo:MatterhornMember 2024-03-31 0001381871 bomo:MatterhornMember 2023-12-31 0001381871 bomo:PremiumOnStockSettledDebtMember bomo:MatterhornMember 2024-03-31 0001381871 bomo:PremiumOnStockSettledDebtMember bomo:TravelDataSolutionsMember 2024-03-31 0001381871 bomo:PremiumOnStockSettledDebtMember bomo:ThirdPartyMember 2024-03-31 0001381871 bomo:PremiumOnStockSettledDebtMember 2024-03-31 0001381871 2021-12-31 0001381871 srt:MinimumMember us-gaap:MeasurementInputSharePriceMember 2024-03-31 0001381871 srt:MaximumMember us-gaap:MeasurementInputSharePriceMember 2024-03-31 0001381871 srt:MinimumMember us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001381871 srt:MaximumMember us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001381871 srt:MinimumMember us-gaap:MeasurementInputExercisePriceMember 2024-03-31 0001381871 srt:MaximumMember us-gaap:MeasurementInputExercisePriceMember 2024-03-31 0001381871 srt:MinimumMember us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001381871 srt:MaximumMember us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001381871 srt:MinimumMember us-gaap:MeasurementInputExpectedTermMember 2024-03-31 0001381871 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember 2024-03-31 0001381871 srt:MinimumMember us-gaap:MeasurementInputExpectedTermMember 2023-12-31 0001381871 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember 2023-12-31 0001381871 srt:MinimumMember us-gaap:MeasurementInputOptionVolatilityMember 2024-03-31 0001381871 srt:MaximumMember us-gaap:MeasurementInputOptionVolatilityMember 2024-03-31 0001381871 srt:MinimumMember us-gaap:MeasurementInputOptionVolatilityMember 2023-12-31 0001381871 srt:MaximumMember us-gaap:MeasurementInputOptionVolatilityMember 2023-12-31 0001381871 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-03-31 0001381871 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-03-31 0001381871 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001381871 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001381871 bomo:MichaelNeeceMember 2022-12-31 0001381871 bomo:MichaelNeeceMember 2023-12-31 0001381871 bomo:MichaelNeeceMember 2024-03-31 0001381871 bomo:EddieAizmanMember 2024-01-01 2024-03-31 0001381871 bomo:MichaelLakshinMember 2024-01-01 2024-03-31 0001381871 bomo:EddieAizmanMember 2022-01-01 2022-12-31 0001381871 bomo:MichaelLakshinMember 2022-01-01 2022-12-31 0001381871 bomo:EddieAizmanMember 2024-03-31 0001381871 bomo:MichaelLakshinMember 2023-12-31 0001381871 bomo:MichaelLakshinMember 2024-03-31 0001381871 2019-07-08 2019-07-08 0001381871 bomo:InterviewMasteryAcquisitionMember 2022-12-16 2022-12-16 0001381871 bomo:InterviewMasteryAcquisitionMember bomo:MichaelRNeeceMember 2022-12-16 2022-12-16 0001381871 bomo:MichaelRNeeceMember 2022-12-16 2022-12-16 0001381871 srt:ChiefExecutiveOfficerMember bomo:MichaelRNeeceMember bomo:ShareBasedCompensationAwardTrancheOneToFourMember 2022-12-16 0001381871 bomo:MichaelRNeeceMember bomo:ShareBasedCompensationAwardTranchePerQuarterMember 2022-12-16 0001381871 bomo:MichaelRNeeceMember 2022-12-16 0001381871 bomo:MichaelRNeeceMember 2023-01-01 2023-12-31 0001381871 bomo:MichaelRNeeceMember 2022-01-01 2022-12-31 0001381871 bomo:PreReverseSplitMember 2022-01-01 2022-12-31 0001381871 bomo:PostReverseSplitMember 2024-01-01 2024-03-31 0001381871 srt:MaximumMember 2024-03-31 0001381871 srt:MinimumMember 2024-03-31 0001381871 srt:MaximumMember us-gaap:WarrantMember 2024-03-31 0001381871 srt:MinimumMember us-gaap:WarrantMember 2024-03-31 0001381871 srt:MinimumMember us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-03-31 0001381871 srt:MaximumMember us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-03-31 0001381871 srt:MinimumMember us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2024-03-31 0001381871 srt:MaximumMember us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2024-03-31 0001381871 srt:MinimumMember us-gaap:WarrantMember us-gaap:MeasurementInputExpectedTermMember 2024-03-31 0001381871 srt:MaximumMember us-gaap:WarrantMember us-gaap:MeasurementInputExpectedTermMember 2024-03-31 0001381871 us-gaap:WarrantMember 2023-12-30 0001381871 us-gaap:WarrantMember 2023-12-31 2023-12-31 0001381871 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001381871 us-gaap:WarrantMember 2024-03-31 0001381871 bomo:SeriesAAAndSuperConvertiblePreferredStockMember 2024-03-31 0001381871 bomo:SeriesAAAndSuperConvertiblePreferredStockMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001381871 bomo:SeriesAAAndSuperConvertiblePreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001381871 bomo:SeriesAAAndSuperConvertiblePreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001381871 bomo:SeriesAAAndSuperConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001381871 bomo:SeriesAConvertiblePreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001381871 bomo:SeriesAConvertiblePreferredStockMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001381871 bomo:SeriesAConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001381871 bomo:SeriesAConvertiblePreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001381871 bomo:SeriesAConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001381871 bomo:SeriesBConvertiblePreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001381871 bomo:SeriesBConvertiblePreferredStockMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001381871 bomo:SeriesBConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001381871 bomo:SeriesBConvertiblePreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001381871 bomo:SeriesBConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001381871 bomo:SeriesCConvertiblePreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001381871 bomo:SeriesCConvertiblePreferredStockMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001381871 bomo:SeriesCConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001381871 bomo:SeriesCConvertiblePreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001381871 bomo:SeriesCConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001381871 bomo:SeriesDConvertiblePreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001381871 bomo:SeriesDConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001381871 bomo:SeriesDConvertiblePreferredStockMember 2024-03-31 0001381871 bomo:SeriesDConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001381871 bomo:SeriesEConvertiblePreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001381871 bomo:SeriesEConvertiblePreferredStockMember 2024-03-31 0001381871 bomo:SeriesEConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001381871 srt:MinimumMember bomo:SeriesEConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001381871 srt:MaximumMember bomo:SeriesEConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001381871 bomo:SeriesFConvertiblePreferredStockMember 2024-03-31 0001381871 bomo:SeriesFConvertiblePreferredStockMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001381871 bomo:SeriesFConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001381871 bomo:SeriesFConvertiblePreferredStockMember us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001381871 bomo:SeriesFConvertiblePreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001381871 bomo:SeriesFConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001381871 bomo:SeriesGConvertiblePreferredStockMember us-gaap:PreferredStockMember 2024-03-31 0001381871 bomo:SeriesGConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001381871 bomo:SeriesGConvertiblePreferredStockMember us-gaap:PreferredStockMember 2023-12-31 0001381871 bomo:SeriesGConvertiblePreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001381871 us-gaap:PreferredStockMember 2021-11-18 0001381871 bomo:SeriesAAPreferredStockMember us-gaap:PreferredStockMember 2021-11-18 0001381871 2017-02-13 2017-02-13 0001381871 bomo:TaxYearExpirable2036Member 2024-03-31 0001381871 bomo:NonExpirableMember 2024-03-31 0001381871 2020-03-27 2020-03-27 0001381871 bomo:CARESActMember 2020-01-01 2020-12-31 0001381871 bomo:ConvertibleNotesMember 2024-01-01 2024-03-31 0001381871 srt:ScenarioForecastMember 2024-10-31 0001381871 srt:ScenarioForecastMember 2024-11-30 0001381871 srt:ScenarioForecastMember 2024-12-31 0001381871 us-gaap:WarrantMember 2024-03-31 0001381871 us-gaap:WarrantMember bomo:ConvertibleNotesMember 2024-03-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

Filing Compare · bowmo, Inc.